Document:

Form of Dealer Agreement

 Exhibit 10.8 
  

			
	

	  	 NICHOLAS FINANCIAL, INC.

Automobile Dealer Retail Agreement

	  

 Non-Recourse Dealer Retail Agreement 

The undersigned Dealer proposes to sell to the undersigned Nicholas Financial, Inc. (NFI), from time to time, Promissory Notes, Security Agreements, Retail
Installment contracts, Conditional Sales Contracts, or other instruments hereinafter referred to as “Contracts”, evidencing installment payment obligations owing Dealer arising from the time sale of motor vehicle(s) and secured by such
Contracts. It is understood that NFI shall have the sole discretion to determine which Contracts it will purchase from Dealer. 
  

	1.	Dealer represents and warrants that Contracts submitted to NFI for purchase shall represent valid, bona fide sales for the respective amount therein set forth in such Contracts and that such Contracts represent sales of
motor vehicles owned by the Dealer and are free and clear of all liens and encumbrances. 

  

	2.	Upon purchase by NFI of any contracts hereunder from dealer, dealer shall endorse and assign to NFI the obligations and all pertinent security, security instruments, along with such provisional endorsements as may be
stipulated for such contracts purchased by NFI. 

  

	3.	This Agreement, and sums payable hereunder, may not be assigned by Dealer without written consent of NFI. 

  

	4.	Dealer acknowledges that NFI charges an acquisition fee and a $75.00 loan processing charge on all contracts purchased and funded by NFI. The acquisition fee and loan processing charge are taken from Dealer Proceeds and
are Non-Refundable. The amount is disclosed on each transaction and is set by Nicholas Financial, Inc. 

  

	5.	Perfection of Security Interest: For each Contract purchased by NFI, Dealer shall, within 20 days of the date of the Contract or within a lesser time period if required by applicable law, file and record
all documents necessary to properly perfect the valid and enforceable first priority security interest of NFI in the Vehicle and shall send NFI all security interest filing receipts. A Contract shall be subject to Repurchase for the life of the
Contract if NFI suffers a loss due to the Dealership’s failure to (1) file and record, within 20 days of the date of the Contract or within a lesser time period if required by applicable law, all documents required to properly perfect the
valid and enforceable first priority security interest of NFI in the Vehicle; (2) send NFI the filing receipts reflecting said perfection. 

  

	6.	Indemnity: As a separate and cumulative obligation, Dealer shall defend and hold NFI harmless from any and all claims, defenses, offsets, damages, suits, administrative or other proceedings, cost
(including reasonable attorney’s fees), expenses, losses, and liabilities. (Collectively Claims) arising out of connected with or relating to the Contract or the goods or services sold there under. Timing of indemnification is within 7 days of
demand by NFI. 

  

	7.	Add-on Products and Services:  

  

	 	a.	Defined. “Add-on Products and Services,” or “APS,” shall mean service contracts, mechanical breakdown contracts, GAP contracts, credit life and credit accident and health insurance. In
addition, the term shall include other products and services acceptable to and approved in writing by NFI from time to time. 

  

	 	b.	Cancellation of APS. If APS has been sold by the Dealer and financed in a Contract purchased by NFI, Dealer agrees that such APS shall be cancelable upon demand by Buyer. Upon such cancellation, Dealer shall
immediately notify NFI that the Buyer has canceled the APS. Upon cancellation, Buyer shall be entitled to a refund of the unearned portion of the cash price of the APS as provided in the APS Contract or as may otherwise be required by law, whichever
is greater. As between NFI and Dealer, Dealer agrees to pay to NFI, as appropriate, any refund due to Buyer under the terms of an APS Contract. Dealer’s liability under this Section shall be limited to the amount Dealer collected and retained
or otherwise received, directly or indirectly, in connection with the sale of the APS. 

  

	8.	Privacy: Dealer shall not make any unauthorized disclosure of, or use any personal information of individual consumers which it receives from NFI or on NFI’s behalf other than to carry out the
purposes for which such information is received. NFI and Dealer shall comply in all respects with all applicable requirements of Title V of the Gramm-Leach-Bliley Act of 1999 and its implementing regulations. 

 

	9.	No Provisions hereof may be modified, changed or supplemented, unless both parties agree to the amendment in writing. 

  

									
	Nicholas Financial, Inc.	 		 	Dealer:	 	  

					
	By:	 	  
	 		 	By:	 	  

					
	Date:	 	  
	 		 	Date:	 	  

	
	 DEALER NAME

	12K & UNDER MOTORS
	1ST CHOICE AUTO BROKERS LLC
	1ST CHOICE AUTO SALES INC
	1ST CHOICE MOTORS
	1ST CLASS AUTO SALES
	1ST STOP MOTORS INC
	247 AUTO SALES
	301CARSALES.COM
	31 W AUTO BROKERS INC
	40 HIGHWAY AUTO SALES LLC
	4042 MOTORS LLC
	5 STAR AUTO SALES
	5 STAR INDY AUTO LLC
	60 WEST AUTO SALES LLC
	83 AUTO SALES LLC
	A & D MOTORS, INC.
	A & S GRAND AVE
	A 1 AUTO SALES INC
	A LOT OF USED CARS
	A LUXURY AUTO
	A PLUS CAR SALES & RENTALS INC
	A.R.J.’S AUTO SALES, INC
	A-1 AUTO GROUP LLC
	AAA AUTOMOTIVE LLC
	AAB INTERNATIONAL AUTO SALES
	AACC AUTO CAR SALES, INC
	ABBY’S AUTOS, INC.
	ABERNETHY CHRYSLER JEEP DODGE
	ACCURATE AUTOMOTIVE OF
	ACTIVE AUTO SALES
	ADAMSON FORD LLC
	ADS AUTO DISCOUNT SALES INC
	ADVANCE AUTO WHOLESALE, INC.
	ADVANCED AUTO & TRUCK
	ADVANCED AUTO BROKERS, INC.
	ADVENTURE SUBARU LLC
	AFFORDABLE AUTO MOTORS, INC
	AIRPORT CHRYSLER DODGE JEEP
	AJ’S AUTO
	AK IMPORTS AUTO SALES
	AL PIEMONTE SUZUKI INC
	ALABAMA DIRECT AUTO
	ALFA MOTORS
	ALL ABOUT AUTO’S INC

	
	 DEALER NAME

	ALL AMERICAN AUTO MART
	ALL CARS LLC
	ALL IN ONE AUTOMOTIVE GROUP
	ALL SEASON AUTO SALES LLC
	ALL STAR AUTO SALES
	ALL STAR DODGE CHRYSLER JEEP
	ALL STAR MOTORS INC
	ALLAN VIGIL FORD
	ALLANS SHOWCASE
	ALLEN TURNER AUTOMOTIVE
	ALLSTAR MOTORS, INC.
	ALMA CHEVROLET BUICK GMC
	ALPHA MOTORS LLC
	AL’S AUTO MART
	ALTERNATIVES
	ALWAYS APPROVED AUTO LLC
	AMERICAN AUTO SALES OF CLOVER
	AMERICAN AUTO SALES WHOLESALE
	AMERICAN PRESTIGE AUTOS INC
	AMERICAN SALES & LEASING INC
	AMERIFIRST AUTO CENTER, INC.
	AMG AUTO SALES INC
	AMS CARS
	ANDY MOHR BUICK PONTIAC GMC
	ANDY MOHR CHEVROLET, INC.
	ANDY MOHR FORD, INC.
	ANDY MOHR TOYOTA
	ANSWER ONE MOTORS
	ANTHONY PONTIAC GMC BUICK INC
	ANTHONY WAYNE AUTO SALES
	ANTIQUE MOTORS
	APPROVAL AUTO CREDIT INC.
	AR MOTORSPORTS INC
	ARB WHOLESALE CARS INC
	ARC AUTO LLC
	ARCH AUTO SALES
	ARDMORE AUTO SALES LLC
	ARENA AUTO SALES
	ARES FINANCIAL SERVICES LLC
	ARMSTRONG FORD OF HOMESTEAD
	ASANKA CARS.COM
	ATA TRUCK & AUTO SALES
	ATCHINSON FORD SALES
	ATL AUTO TRADE INC

 
 

	
	 DEALER NAME

	ATL AUTOS .COM
	ATLANTA BEST USED CARS LLC
	ATLANTA LUXURY MOTORS INC
	ATLANTA USED CARS CENTER, INC
	ATLANTIS RENT A CAR AND
	AUCTION DIRECT USA
	AURORA MOTOR CARS
	AUTO ACCEPTANCE CENTER
	AUTO AMERICA
	AUTO BANK, INC.
	AUTO BROKERS, INC.
	AUTO CENTERS NISSAN INC
	AUTO CENTERS ST CHARLES LLC
	AUTO CITY LLC
	AUTO CLUB OF MIAMI
	AUTO CREDIT
	AUTO DIRECT
	AUTO DIRECT COLUMBUS OH
	AUTO DIRECT PRE-OWNED
	AUTO EXCHANGE
	AUTO EXCHANGE
	AUTO EXCHANGE OF DURHAM
	AUTO EXPRESS CREDIT INC
	AUTO EXPRESS ENTERPRISE INC
	AUTO FINDERS, INC.
	AUTO GALAXY INC
	AUTO ICONS LLC
	AUTO LAND AUTO SALES INC
	AUTO LIAISON INC
	AUTO LIBERTY OF ARLINGTON
	AUTO LINE, INC.
	AUTO MALL OF TAMPA INC
	AUTO MASTERS AUTO SALES LLC
	AUTO MASTERS OF NASHVILLE LLC
	AUTO MAX
	AUTO MEGA STORE LLC
	AUTO NETWORK OF THE TRIAD LLC
	AUTO PARK CORPORATION
	AUTO PLAZA USA
	AUTO PLUS OF SMITHVILLE LLC
	AUTO POINT USED CAR SALES
	AUTO PORT
	AUTO PROFESSION CAR SALES 2
	AUTO PROFESSIONAL CAR SALES

	
	 DEALER NAME

	AUTO RITE, INC
	AUTO SALES OF WINTER GARDEN
	AUTO SELECT
	AUTO SELECT INC
	AUTO SELECTION OF CHARLOTTE
	AUTO SENSATION USA, INC.
	AUTO SOURCE
	AUTO SOURCE CAROLINA LLC
	AUTO SPECIALISTS
	AUTO SPORT, INC.
	AUTO STOP INC
	AUTO TRADEMARK
	AUTO TRUST LLC
	AUTO UNION OF MIAMI INC
	AUTO VILLA
	AUTO VILLA OUTLET
	AUTO VILLA WEST
	AUTO WAREHOUSE INC
	AUTO WEEKLY SPECIALS
	AUTO WISE AUTO SALES
	AUTO WORLD
	AUTO WORLD
	AUTOBRANCH
	AUTODRIVE, LLC
	AUTOLANTA COLLECTION
	AUTOMAC USA INC
	AUTOMART #1 LLC
	AUTOMAX
	AUTOMAX
	AUTOMAX AUTO SALES INC
	AUTOMAX CHRYSLER DODGE JEEP
	AUTOMAX OF ANDERSON
	AUTOMAX OF GREENVILLE
	AUTOMOTIVE DIRECT USA INC
	AUTOMOTIVE GROUP OF OFALLON/CO
	AUTONATION IMPORTS AUTO SALES
	AUTONET GROUP LLC
	AUTONOMICS
	AUTOPLEX
	AUTOPLEX IMPORT
	AUTOQUICK, INC.
	AUTORAMA PREOWNED CARS
	AUTOS BEST INC
	AUTOS DIRECT INC

 
 

	
	 DEALER NAME

	AUTOS DIRECT ONLINE
	AUTOS R US
	AUTOSHOW SALES AND SERVICE
	AUTOSPORTS
	AUTOWAY CHEVROLET
	AUTOWAY FORD OF BRADENTON
	AUTOWORLD USA
	AVENUE AUTO AND RV
	AVIS FORD
	B & B ELITE AUTO SALES LLC
	B & W MOTORS
	BAKER’S BODY SHOP
	BALLAS BUICK GMC
	BALLPARK AUTO LLC
	BANK AUTO SALES
	BARBIES AUTOS CORPORATION
	BARGAIN SPOT CENTER
	BARNES USED CARS LLC
	BARRY BROWN MOTORS LLC
	BARTOW FORD COMPANY
	BARTS CAR STORE
	BARTS CAR STORE INC
	BARTS CAR STORE INC
	BASELINE AUTO SALES, INC.
	BATES FORD INC
	BEACH AUTO KINGS
	BEACHSIDE RIDE
	BEACHUM AND LEE FORD INC
	BEAU TOWNSEND NISSAN, INC.
	BEDFORD AUTO WHOLESALE
	BEECHMONT FORD
	BEEJAY AUTO SALES INC
	BEFORD AUTO
	BEHLMANN ST PETERS PREOWNED
	BELAIR ROAD DISCOUNT AUTO
	BELLS AUTO SALES
	BELL’S AUTO SALES
	BENJI AUTO SALES CORP
	BENSON CADILLAC NISSAN, INC.
	BENSON FORD MERCURY
	BENSON HYUNDAI LLC
	BENSON NISSAN
	BEREA AUTO MALL
	BERGER CHEVROLET

	
	 DEALER NAME

	BERKELEY FORD
	BESSEMER AL AUTOMOTIVE LLC
	BEST AUTO SELECTION INC
	BEST BUY AUTO MART LLC II
	BEST BUY AUTO SALES OF TAMPA
	BEST CARS KC INC
	BEST CHEVROLET
	BEST DEAL AUTO SALES
	BEST PRICE DEALER INC
	BEST VALUE AUTO SALES INC
	BESTWAY AUTO BROKERS LLC
	BETTER AUTOMALL LLC
	BEV SMITH KIA
	BEXLEY MOTORCAR COMPANY LLC
	BIG BLUE AUTOS, LLC
	BIG BOYS TOYS FLORIDA LLC
	BIG CHOICES AUTO SALES INC
	BIG M CHEVROLET
	BIG O DODGE OF GREENVILLE, INC
	BILL BLACK CHEVROLET,
	BILL ESTES CHEVROLET
	BILL KAY FORD INC
	BILL MAC DONALD FORD INC
	BILL OWENS AUTO SALES
	BILL STANFORD PONT CAD OLDS GM
	BILLS & SON AUTO SALES INC
	BILLS AUTO SALES & LEASING, LTD
	BILTMORE MOTOR CORP.
	BIRMINGHAM WHOLESALE AUTO LLC
	BLEECKER BUICK-GMC INC
	BLEECKER CHRYSLER DODGE JEEP
	BLOOMINGTON AUTO CENTER
	BLUE SPRINGD FORD SALES INC
	BLUESLADE MOTOR CARS LLC
	BOB JEANNOTTE BUICK GMC TRUCK
	BOB KING MITSUBISHI
	BOB KING’S MAZDA
	BOB MAXEY FORD
	BOB MAXEY LINCOLN-MERCURY
	BOB PULTE CHEVROLET GEO, INC.
	BOB STEELE CHEVROLET INC.
	BOBB CHRYSLER DODGE JEEP RAM
	BOBB SUZUKI
	BOBBY LAYMAN CHEVROLET, INC.

 
 

	
	 DEALER NAME

	BOBBY MURRAY TOYOTA
	BOBILYA CHRYSLER PLYMOUTH
	BOMMARITO CHEVROLET MAZDA
	BONANZA AUTO CENTER INC
	BONIFACE HIERS MAZDA
	BORCHERDING ENTERPRISE, INC
	BOSAK HONDA
	BOULEVARD AUTO EXCHANGE 2 INC
	BOYD AUTOMOTIVE
	BRADLEY CHEVROLET, INC.
	BRAD’S USED CARS
	BRAMLETT PONTIAC INC
	BRANDON AUTO MALL FIAT
	BRANDON HONDA
	BRANDON MITSUBISHI
	BRANNON HONDA
	BRAZIL AUTO MALL INC
	BRECKENRIDGE MOTORS EAST LLC
	BREVARD VALUE MOTORS
	BRICKELL HONDA BUICK & GMC
	BROMAR LLC
	BROMLEY AUTO SALES, LLC
	BRONDES FORD MAUMEE LTD
	BROOKS AUTO SALES
	BROTHERS CHEVROLET OLDSMOBILE
	BROWN MOTOR SALES
	BRYANT AUTO SALES INC
	BUCKEYE CITY AUTOMOTIVE GROUP
	BUCKEYE FORD LINCOLN MERC OF O
	BUCKEYE NISSAN, INC.
	BUSH AUTO PLACE
	BUY RIGHT AUTO SALES INC
	BUYERS CHOICE AUTO CENTER LLC
	BUZZ KARZ LLC
	BYERLY FORD-NISSAN, INC
	BYERS CHEVROLET LLC
	BYERS DELAWARE
	BYERS KIA
	C & J AUTO WORLD LLC
	C & S SALES
	CADILLAC OF NOVI INC
	CALDERONE CAR AND TRUCK
	CALIFORNIA AUTO CONNECTION INC
	CALVARY CARS & SERVICE, INC

	
	 DEALER NAME

	CAMPBELL CHEVOFBOWLGREENKYINC
	CANCILA MARTY DODGE CHRYSLER J
	CAPITAL AUTO BROKERS
	CAPITAL BUICK PONTIAC GMC LLC
	CAPITAL MOTORS
	CAPITAL MOTORS LLC
	CAPITAL MOTORS LLC
	CAPITOL AUTO SALES, INC.
	CAPITOL CADILLAC
	CAR AMERICA LLC
	CAR BAZAAR INC OF FRANKLIN
	CAR BIZ OF TENNESSEE
	CAR CITY USA LLC
	CAR CONCEPTS REMARKETING
	CAR COUNTRY
	CAR CREDIT INC
	CAR CREDIT XPRESS
	CAR DEPOT
	CAR FACTORY OUTLET
	CAR FINDERS, LLC
	CAR MART FL.COM
	CAR NATION
	CAR SOURCE, LLC.
	CAR YEP LLC
	CAR ZONE
	CARDINAL MOTORS INC
	CARDIRECT LLC
	CAREY PAUL HONDA
	CARMART AUTO SALES
	CARMART AUTO SALES, INC.
	CARMART AUTOMALL LLC
	CARMAXX LLC
	CAROLINA AUTO EXCHANGE
	CAROLINA AUTO SPORTS
	CAROLINA MOTORCARS
	CARPLUS AUTO SALES INC
	CARPORT SALES & LEASING, INC.
	CARROLLTON MOTORS
	CARS & CREDIT OF FLORIDA
	CARS & TRUCKS
	CARS 4 LESS LLC
	CARS DIRECT
	CARS GONE WILD II LLC
	CARS N CARS, INC.

 
 

	
	 DEALER NAME

	CARS OF JAX INC
	CARS PLUS CREDIT LLC
	CARS PLUS LLC
	CARS TO GO AUTO SALES AND
	CARS TRUCKS & MORE INC
	CARS UNLIMITED
	CARS YOU CAN TRUST
	CARSMART AUTO SALES LLC
	CARSMART, INC.
	CARTROPIX
	CARXPRESS
	CARZ N TRUX
	CARZ, INC.
	CARZZ AUTO SALES INC
	CAS SALES & RENTALS
	CASH AUTO SALES LLC
	CASTRIOTA CHEVROLET GEO INC.
	CAVALIER AUTO SALES INC
	CC MOTORS INC
	CD S AUTOMOTIVE
	CENTRAL 1 AUTO BROKERS
	CENTRAL FLORIDA EXPORTS, INC.
	CENTRAL MOTOR WERKS, INC
	CENTRAL PONTIAC INC.
	CERTIFIED AUTO CENTER
	CERTIFIED AUTO DEALERS
	CHAMPION CHEVROLET
	CHAMPION OF DECATUR, INC.
	CHAMPION PREFERRED AUTOMOTIVE
	CHAMPION TRUCK CENTER LLC
	CHARLES BARKER PREOWNED OUTLET
	CHARLOTTE MOTOR CARS LLC
	CHARS CARS LLC
	CHASE AUTO GROUP
	CHATHAM PARKWAY TOYOTA
	CHESAPEAKE AUTO GROUP
	CHESTATEE FORD INC
	CHEVROLET BUICK OF QUINCY INC.
	CHEVROLET OF DUBLIN
	CHICAGO AUTO DEPOT INC
	CHICAGO AUTO SOURCE INC
	CHICAGO MOTORS INC
	CHRIS CARROLL AUTOMOTIVE
	CHRIS LEITH AUTOMOTIVE INC

	
	 DEALER NAME

	CHRIS MOTORS AUTO SALES
	CHRIS SPEARS PRESTIGE AUTO
	CHRYSLER JEEP OF DAYTON
	CINCINNATI AUTO WORKS
	CIRCLE CITY ENTERPRISES, INC.
	CITY AUTO SALES
	CITY IMPORT GALLERY LLC
	CITY MOTORS FLORIDA LLC
	CITY STYLE IMPORTS INC
	CITY TO CITY AUTO SALES, LLC
	CLARK CARS INC
	CLARKSVILLE AUTO SALES
	CLASSY AUTO SALES CORP
	CLEAN CARS
	CLEARANCE AUTO STORE
	CLEARWATER CARS INC
	CLEARWATER TOYOTA
	CLIFF & SONS AUTO SALES
	CLIFT BUICK GMC
	COASTAL AUTO GROUP INC. DBA
	COASTAL AUTO, INC.
	COCONUT CREEK HYUNDAI
	COGGIN HONDA
	COGGIN NISSAN
	COLE FORD LINCOLN LLC
	COLUMBUS AUTO RESALE, INC
	COLUMBUS AUTO SOURCE
	COLUMBUS AUTO WAREHOUSE LLC
	COLUMBUS CAR TRADER
	COMMONWEALTH DODGE LLC
	CONCOURS AUTO SALES, INC.
	CONEXION AUTO SALES
	CONWAY HEATON INC
	CONWAY IMPORTS AUTO SALES
	COOK & REEVES CARS INC
	COOKE’S AUTO SALES
	COOK-WHITEHEAD FORD, INC
	COPELAND MOTOR COMPANY
	CORAL WAY AUTO SALES INC
	CORLEW CHEVROLET CADILLAC OLDM
	CORPORATE FLEET MANAGEMENT
	CORTEZ MOTORS
	COTTAGEVILLE MOTOR SALES INC
	COUGHLIN AUTOMOTIVE- PATASKALA

 
 

	
	 DEALER NAME

	COUGHLIN CHEVROLET- NEWARK
	COUGHLIN FORD OF CIRCLEVILLE
	COUGLIN CHEVROLET BUICK CADILL
	COUNTRY HILL MOTORS INC
	COUNTRY HILL MOTORS, INC.
	COUNTRYSIDE FORD OF CLEARWATER
	COURTESY CHRYSLER JEEP DODGE
	COURTESY NISSAN
	COWBOYS WHOLESALE INC
	COX AUTO SALES
	COYLE CHEVROLET
	CRABBS AUTO SALES
	CRAIG & BISHOP, INC.
	CRAMER HONDA OF VENICE
	CRAMER TOYOTA OF VENICE
	CREDIT CARS USA
	CREDIT MASTER AUTO SALE INC
	CREDIT SOLUTION AUTO SALES INC
	CREDIT UNION REMARKETING
	CRENCOR LEASING & SALES
	CRESTMONT HYUNDAI, LLC
	CRM MOTORS, INC.
	CRONIC CHEVROLET OLDSMOBILE
	CRONIC CHEVROLET, OLDSMOBILE-
	CROSSROADS AUTO SALES INC
	CROSSROADS FORD INC
	CROWN ACURA
	CROWN AUTO & FLEET SERVICES
	CROWN AUTO GROUP INC
	CROWN AUTOS
	CROWN BUICK GMC
	CROWN EUROCARS INC
	CROWN HONDA
	CROWN KIA
	CROWN KIA
	CROWN MITSUBISHI
	CROWN MOTORS INC
	CROWN NISSAN
	CROWN NISSAN
	CRUISER AUTO SALES
	CURRIE MOTORS FRANKFORT INC
	CURRY HONDA
	CUSTOM CAR CARE
	D & D ALL AMERICAN AUTO SALES

	
	 DEALER NAME

	D & J MOTORS, INC.
	DADE CITY AUTOMAX
	DAN CUMMINS CHV BUICK PONTIAC
	DAN TUCKER AUTO SALES
	DANE’S AUTO SALES LLC
	DAVCO AUTO LLC
	DAVE SINCLAIR LINCOLN
	DAVES JACKSON NISSAN
	DAVID SMITH AUTOLAND, INC.
	DAWSONS AUTO & TRUCK SALES INC
	DAYTON ANDREWS DODGE
	DBA AUTONATION CHEVROLET
	DEACON JONES AUTO PARK
	DEACON JONES NISSAN LLC
	DEALERS CHOICE MOTOR COMPANY
	DEALS 4 U AUTO LLC
	DEALS ON WHEELS
	DEALZ AUTO TRADE
	DEALZ ON WHEELZ LLC
	DEAN SELLERS, INC.
	DEFOUW CHEVROLET, INC.
	DELRAY HONDA
	DELUCA TOYOTA INC
	DELUXE MOTORS, INC.
	DENNIS AUTO POINT
	DENNY’S AUTO SALES, INC.
	DEPENDABLE MOTOR VEHICLES INC
	DEPUE AUTO SALES INC
	DEREK MOTORCAR CO INC
	DESTINYS AUTO SALES
	DETROIT AUTO PARTS LLC
	DETROIT II AUTOMOBILES
	DEWEY BARBER’S F1 MOTORCARS
	DEWITT MOTORS
	DI LUSSO MOTORCARS
	DIAMOND MOTORS OF DAYTONA
	DIANE SAUER CHEVROLET, INC.
	DICK BROOKS HONDA
	DICK MASHETER FORD, INC.
	DICK SCOTT NISSAN, INC.
	DICK WICKSTROM CHEVROLET INC
	DIMMITT CHEVROLET
	DISCOUNT AUTO SALES
	DISCOVERY AUTO GROUP

 
 

	
	 DEALER NAME

	DIVERSIFIED AUTO SALES
	DIXIE IMPORT INC
	DIXIE WAY MOTORS INC
	DM MOTORS, INC.
	DODGE OF ANTIOCH INC
	DON AYERS PONTIAC INC
	DON FRANKLIN CHEVROLET, BUICK
	DON HINDS FORD, INC.
	DON JACKSON CHRYSLER DODGE
	DON JACKSON IMPORTS CARS INC
	DON MARSHALL CHYSLER CENTER
	DON REID FORD INC.
	DORAL CARS OUTLET
	DOWNTOWN BEDFORD AUTO
	DRAKE MOTOR COMPANY
	DRIVE NOW AUTO SALES
	DRIVE SMART AUTOS
	DRIVER SEAT AUTO SALES LLC
	DRIVERIGHT AUTO SALES, INC.
	DRIVERS WORLD
	DRIVEWAY MOTORS
	DRIVEWAYCARS.COM
	DRY RIDGE TOYOTA
	DUBLIN CADILLAC NISSAN GMC
	DUVAL CARS LLC
	DUVAL FORD
	DYNASTY MOTORS
	E & R AUTO SALES INC
	EAGLE LAKE CARS
	EAGLE ONE AUTO SALES
	EARL TINDOL FORD, INC.
	EASLEY MITSUBISHI’S THE
	EAST ANDERSON AUTO SALES
	EASTERN SHORE AUTO BROKERS INC
	EASTGATE MOTORCARS, INC
	EASY AUTO AND TRUCK
	EASY FINANCE AUTO
	EAZY RIDE AUTO SALES LLC
	ECONO AUTO SALES INC
	ECONOMIC AUTO SALES INC
	ED NAPLETON HONDA
	ED TILLMAN AUTO SALES
	ED VOYLES HONDA
	ED VOYLES HYUNDAI

	
	 DEALER NAME

	ED VOYLES KIA OF CHAMBLEE
	EDDIE ANDRESON MOTORS
	EDDIE MERCER AUTOMOTIVE
	EDGE MOTORS
	EDWARDS CHEVROLET CO
	EJ’S QUALITY AUTO SALES, INC.
	ELITE AUTO SALES OF ORLANDO
	ELITE AUTO WHOLESALE
	ELITE AUTOMOTIVE GROUP
	ELITE CAR SALES WEST INC
	ELITE MOTORS, INC.
	ELYRIA BUDGET AUTO SALES INC
	EMJ AUTOMOTIVE REMARKETING
	EMPIRE AUTO SALES & SERVICE
	EMPIRE AUTOMOTIVE GROUP
	ENON AUTO SALES
	ENTERPRISE
	ENTERPRISE CAR SALES
	ENTERPRISE CAR SALES
	ENTERPRISE CAR SALES
	ENTERPRISE CAR SALES
	ENTERPRISE CAR SALES
	ENTERPRISE LEASING COMPANY
	ENTERPRISE LEASING COMPANY
	ERNEST MOTORS, INC.
	ERNIE PATTI AUTO LEASING &
	ERWIN CHRYSLER PLYMOUTH DODGE
	ESTERO BAY CHEVROLET INC
	ESTLE CHEVROLET CADILLAC
	EVANS AUTO SALES
	EVERYDAY AUTO SALES
	EXCLUSIVE AUTOMOTIVE LLC
	EXCLUSIVE MOTOR CARS LLC
	EXCLUSIVE MOTORCARS LLC
	EXECUTIVE AUTO SALES
	EXECUTIVE CARS LLC
	EXECUTIVE MOTORS
	EXPRESS AUTO SALES
	EXPRESS MOTORS LLC
	EXTREME DODGE DODGE TRUCK
	EZ AUTO & TRUCK PLAZA II INC
	E-Z WAY CAR SALES & RENTALS
	FAIRLANE FORD SALES, INC.
	FAITH MOTORS, INC.

 
 

	
	 DEALER NAME

	 FALCONE AUTOMOTIVE

	 FAME FINANCE COMPANY

	 FAMILY KIA

	 FANELLIS AUTO

	 FANTASTIC 4 AUTO SALES

	 FAST AUTO SALES, LLC

	 FASTLANE AUTO CREDIT INC

	 FENTON NISSAN OF BLUE SPRINGS

	 FERMAN CHEVROLET

	 FERMAN CHRYSLER JEEP DODGE AT

	 FERMAN CHRYSLER PLYMOUTH

	 FERMAN NISSAN

	 FIAT OF SAVANNAH

	 FIAT OF SOUTH ATLANTA

	 FIAT OF WINTER HAVEN

	 FINDLAY CHRY DODGE JEEP RAM

	 FIRKINS C.P.J.S.

	 FIRKINS NISSAN

	 FIRST CHOICE AUTOMOTIVE INC

	 FIRST STOP AUTO SALES

	 FIRST UNION AUTOMOTIVE LLC

	 FISCHER NISSAN INC.

	 FITZGERALD MOTORS, INC.

	 FIVE STAR CAR & TRUCK

	 FIVE STAR DODGE

	 FL PRICE BUSTER AUTO SALES

	 FLAMINGO AUTO SALES

	 FLORENCE AUTO MART INC

	 FLORIDA AUTO EXCHANGE

	 FLORIDA FINE CARS INC

	 FLORIDA TRUCK SALES

	 FLOW HONDA

	 FLOW MOTORS

	 FMC AUTO SALES INC

	 FORD OF PORT RICHEY

	 FOREMAN MOTORS, INC.

	 FORT WALTON BEACH

	 FORT WAYNE AUTO CONNECTION LLC

	 FORT WAYNE NISSAN INFINITI

	 FORTUNE MOTOR GROUP

	 FRANK MYERS AUTO SALES, INC

	 FRANK SHOOP CHEVY BUICK PONTIA

	 FRED ANDERSON KIA

	 FRED ANDERSON NISSAN OF RALEIG

	
	 DEALER NAME

	 FREEDOM AUTO SALES

	 FRENSLEY CHRYSLER PLYMOUTH

	 FRIENDLY FINANCE AUTO SALES

	 FRITZ ASSOCIATES

	 FRONTIER MOTORS INC

	 FRONTLINE AUTO SALES

	 G & R AUTO SALES CORP

	 G & W MOTORS INC

	 GABE ROWE NISSAN

	 GAINESVILLE MITSUBISHI

	 GANLEY CHEVROLET, INC

	 GANLEY CHRYSLER JEEP DODGE INC

	 GANLEY EAST, INC

	 GANLEY FORD WEST, INC.

	 GARY SMITH FORD

	 GARY YEOMANS FORD

	 GARYS I-75 AUTO SALES LLC

	 GATES CHEV PONT GMC BUICK

	 GATES NISSAN, LLC

	 GATEWAY AUTOMOTIVE SALES &

	 GATOR CHRYSLER-PLYMOUTH, INC.

	 GATOR TRUCK CENTER INC

	 GENE GORMAN & ASSOC. INC. DBA

	 GENERAL AUTO LLC

	 GENTHE AUTOMOTIVE-EUREKA LLC

	 GEOFF ROGERS AUTOPLEX

	 GEORGE WEBER CHEVROLET CO

	 GEORGETOWN AUTO SALES

	 GEORGIA AUTO WORLD LLC

	 GEORGIA CHRYSLER DODGE

	 GERMAIN TOYOTA

	 GERMAIN TOYOTA

	 GERWECK NISSAN

	 GET DOWN MOTORS INC

	 GETTEL NISSAN OF SARASOTA

	 GETTEL TOYOTA

	 GINN MOTOR COMPANY

	 GLADSTONE AUTO INC

	 GLEN BURNIE AUTO EXCHANGE, INC

	 GLENDALE CHRYSLER JEEP INC

	 GLENN BUICK GMC TRUCKS

	 GLOBAL AUTO EXPO INC

	 GLOBAL MOTORS INC

	 GLOBE AUTO SALES

 

	
	 DEALER NAME

	 GLOVER AUTO SALES

	 GMOTORCARS INC

	 GMT AUTO SALES, INC

	 GOLDEN OLDIES

	 GOLLING CHRYSLER JEEP

	 GOOD BAD NO CREDIT AUTO SALES

	 GOOD CARS

	 GOOD CARS

	 GOOD MOTOR COMPANY

	 GOODMAN CHEV OLDS CAD NISSAN

	 GR MOTOR COMPANY

	 GRACE AUTOMOTIVE LLC

	 GRAINGER NISSAN

	 GRANT MOTORS CORP.

	 GRAVITY AUTOS ATLANTA

	 GRAVITY AUTOS ROSWELL

	 GREAT BRIDGE AUTO SALES

	 GREAT INVESTMENT MOTORS

	 GREAT LAKES HYUNDAI, INC.

	 GREEN LIGHT CAR SALES

	 GREEN TREE TOYOTA

	 GREENLIGHT MOTORS, LLC

	 GREEN’S TOYOTA

	 GREENWISE MOTORS

	 GREER NISSAN

	 GREG SWEET FORD INC

	 GRIFFIN FORD SALES, INC.

	 GRIMALDI AUTO SALES INC

	 GROGANS TOWNE CHRYSLER

	 GROUND ZERO MIAMI CORPORATION

	 GROW AUTO FINANCIAL INC

	 GTO AUTO SALES INC

	 GUARANTEE AUTOMAXX CORPORATION

	 GULF ATLANTIC WHOLESALE INC

	 GULF COAST AUTO BROKERS, INC.

	 GUPTON MOTORS INC

	 GWINNETT SUZUKI

	 H & H AUTO SALES

	 H & H AUTO SALES

	 HAIMS MOTORS INC

	 HALLMAN AUTOMOTIVE

	 HAMILTON CHEVROLET INC

	 HAMMCO INC

	
	 DEALER NAME

	 HANNA IMPORTS

	 HANS AUTO

	 HAPPY AUTO MART

	 HAPPY CARS INC

	 HARBOR CITY AUTO SALES, INC.

	 HARBOR NISSAN

	 HARDIE’S USED CARS, LLC

	 HARDY CHEVROLET

	 HARRIET SALLEY AUTO GROUP LLC

	 HARTLEY MOTORS INC

	 HAWK FORD OF OAK LAWN

	 HAWKINSON NISSAN LLC

	 HEADQUARTER TOYOTA

	 HEARTLAND CHEVROLET

	 HENDRICK HONDA

	 HENDRICKSCARS.COM

	 HENNESSY MAZDA PONTIAC

	 HERITAGE AUTOMOTIVE GROUP

	 HERITAGE CADILLAC-OLDS, INC.

	 HERITAGE MOTOR COMPANY

	 HERITAGE NISSAN

	 HERRINGTON AUTOMOTIVE

	 HIGH Q AUTOMOTIVE CONSULTING

	 HIGHLINE IMPORTS, INC.

	 HIGHWAY 31 AUTO SALES LLC

	 HILL NISSAN INC

	 HILLTOP MOTORS

	 HILTON HEAD MITSUBISHI

	 HOGSTEN AUTO WHOLESALE

	 HOLIDAY MOTORS

	 HOLLYWOOD MOTOR CO #1

	 HOLLYWOOD MOTOR CO #3

	 HOMESTEAD MOTORS

	 HOMETOWN AUTO MART, INC

	 HONDA CARS OF BRADENTON

	 HONDA CARS OF ROCK HILL

	 HONDA MARYSVILLE

	 HONDA OF FRONTENAC

	 HONDA OF GAINESVILLE

	 HONDA OF OCALA

	 HONDA OF TIFFANY SPRINGS

	 HONEYCUTT’S AUTO SALES, INC.

	 HOOVER AUTOMOTIVE LLC

	 HOOVER CHRYSLER PLYMOUTH

 

	
	 DEALER NAME

	 DODGE

	 HOOVER MITSUBISHI CHARLESTON

	 HOOVER TOYOTA, LLC

	 HORACE G ILDERTON

	 HORIZON CARS

	 HT MOTORS INC

	 HUBLER AUTO PLAZA

	 HUBLER FINANCE CENTER

	 HUBLER MAZDA SOUTH

	 HUDSON AUTO SALES

	 HUGH WHITE HONDA

	 HUNT AUTOMOTIVE, LLC

	 HWY 150 BUYERS WAY, INC.

	 HYUNDAI OF BRADENTON

	 HYUNDAI OF GREER

	 HYUNDAI OF LOUISVILLE

	 HYUNDAI OF NICHOLASVILLE

	 HYUNDIA OF ORANGE PARK

	 HZF PLAINWELL

	 I 95 TOYOTA & SCION

	 IDEAL USED CARS INC

	 IMAGINE CARS

	 IMPERIAL MOTORS

	 IMPERIAL SALES & LEASING INC

	 IMPEX AUTO SALES

	 INDIAN RIVER LEASING CO

	 INDY AUTO LAND LLC

	 INDY AUTO MAN LLC

	 INDY’S UNLIMITED MOTORS

	 INTEGRITY AUTO PLAZA LLC

	 INTEGRITY AUTO SALES

	 INTEGRITY AUTO SALES INC

	 INTEGRITY AUTOMOTIVE

	 INTERCAR

	 INTERNATIONAL AUTO LIQUIDATORS

	 INTERNATIONAL AUTO OUTLET

	 INTERNATIONAL AUTO WHOLESALERS

	 INTERNATIONAL FINE CARS LLC

	 INTERSTATE MOTORS LLC

	 J & C AUTO SALES

	 J & J FINANCE AND LEASING INC

	 J & M AFFORDABLE AUTO, INC.

	 J AND J MOTORSPORTS LLC

	 J&B AUTO SALES & BROKERAGE

	
	 DEALER NAME

	 J.W. TRUCK SALES, INC.

	 JACK DEMMER FORD, INC.

	 JACK MAXTON CHEVROLET INC

	 JACK MAXTON CHEVROLET, INC

	 JACK MAXTON USED CARS

	 JACK MILLER KIA

	 JACK STONES CREEKSIDE SALES

	 JACKIE MURPHY’S USED CARS

	 JACKSONVILLE AUTO SALES LLC

	 JAKE SWEENEY CHEVROLET, INC

	 JAKE SWEENEY CHRYSLER JEEP

	 JAKES USED CARS LLC

	 JAKMAX

	 JAMESTOWN AUTO SALES INC

	 JARRARD PRE-OWNED VEHICLES

	 JARRETT FORD OF PLANT CITY

	 JARRETT GORDON FORD INC

	 JAX AUTO WHOLESALE, INC.

	 JAY CHEVROLET, INC

	 JAY HONDA

	 JAY WOLFE AUTO OUTLET

	 JC AUTOMAX

	 JC LEWIS FORD, LLC

	 JDF AUTO

	 JEFF WYLEF CHEVROLET OF

	 JEFF WYLER DIXIE CHEVROLET

	 JEFF WYLER DIXIE HONDA

	 JEFFREY P. HYDER

	 JEFFREYS AUTO EXCHANGE

	 JEMS AUTO SALES INC

	 JENISON MOTOR SALES LLC

	 JENKINS NISSAN, INC.

	 JERRY HAGGERTY CHEVROLET INC

	 JERRY WILSON’S MOTOR CARS

	 JESSE’S AUTO SALES INC

	 JEWEL AUTO SALES

	 JIDD MOTORS INC

	 JIM BURKE NISSAN

	 JIM BUTLER AUTO PLAZA

	 JIM COGDILL DODGE CO

	 JIM DOUGLAS SALES AND SERVICE

	 JIM KEIM FORD

	 JIM M LADY OLDSMOBILE INC

	 JIM ORR AUTO SALES

 

	
	 DEALER NAME

	 JIM SKINNER FORD INC

	 JIM SOUTHWORTH FORD INC

	 JIM WHITE HONDA

	 JIM WOODS AUTOMOTIVE, INC.

	 JIMMIE VICKERS INC.

	 JIMMY SMITH PONTIAC BUICK GMC

	 JK AUTOMOTIVE GROUP LLC

	 JMC AUTO BROKERS INC

	 JODECO AUTO SALES

	 JOE FIRMENT CHEVROLET

	 JOE KIDD AUTOMOTIVE INC

	 JOE WINKLE’S AUTO SALES LLC

	 JOHN BLEAKLEY FORD

	 JOHN HIESTER CHEVROLET

	 JOHN HINDERER HONDA

	 JOHN JENKINS, INC.

	 JOHN JONES AUTOMOTIVE

	 JOHN SNYDER AUTO MART, INC.

	 JOHNNY WRIGHT AUTO SALES LLC

	 JOHNNYS MOTOR CARS LLC

	 JOHNSON AUTOPLEX

	 JOSEPH CHEVROLET OLDSMOBILE CO

	 JOSEPH MOTORS

	 JOSEPH TOYOTA INC.

	 JT AUTO INC.

	 JULIANS AUTO SHOWCASE, INC.

	 JUST-IN-TIME AUTO SALES INC

	 K & M SUZUKI

	 K T AUTO SALES LLC

	 KACHAR’S USED CARS, INC.

	 KAHLER AUTO SALES LLC

	 KALER LEASING SERVICES INC

	 KARGAR, INC.

	 KASPER CHRYSLER DODGE JEEP

	 KATHY’S KARS

	 KC TREND AUTO

	 KDK AUTO BROKERS

	 KEFFER PRE-OWNED SOUTH

	 KEITH HAWTHORNE HYUNDAI, LLC

	 KEITH PIERSON TOYOTA

	 KELLEY BUICK GMC INC

	 KELLY & KELLY INVESTMENT CO IN

	 KELLY FORD

	 KENDALL MITSUBISHI

	
	 DEALER NAME

	 KENDALL TOYOTA

	 KENNYS AUTO SALES, INC

	 KEN’S AUTOS

	 KENS KARS

	 KERRY TOYOTA

	 KEY CHRYLSER PLYMOUTH INC

	 KIA ATLANTA SOUTH

	 KIA AUTO SPORT

	 KIA COUNTRY OF SAVANNAH

	 KIA OF CANTON

	 KING AUTOMOTIVE, LLC

	 KING MOTORS

	 KING SUZUKI OF HICKORY LLC

	 KINGS AUTO GROUP INC

	 KINGS AUTOMOTIVE INC

	 KING’S COLONIAL FORD

	 KINGS FORD, INC

	 KINGS HONDA

	 KINGS OF QUALITY AUTO SALES

	 KLASSIC CARS LLC

	 KMAX INC

	 KNAPP MOTORS

	 KNE MOTORS, INC.

	 KNH WHOLESALE

	 KNOX BUDGET CAR SALES & RENTAL

	 KOE-MAK CORP

	 KOETTING FORD INC

	 KUHN MORGAN TOYOTA SCION

	 KUNES COUNTY FORD OF ANTIOCH

	 L & J AUTO SALES CORP

	 LA AUTO STAR, INC.

	 LAFONTAINE AUTO GROUP

	 LAGRANGE MOTORS

	 LAKE HARTWELL HYUNDAI

	 LAKE NISSAN SALES, INC.

	 LAKE NORMAN MOTORS LLC

	 LAKE PLACID MOTOR CAR, INC

	 LAKE ST LOUIS AUTO

	 LAKE WALES CHRSYLER DODGE

	 LAKELAND AUTO MALL

	 LAKELAND TOYOTA INC.

	 LAKESIDE MOTORS

	 LALLY ORANGE BUICK PONTIAC GMC

	 LANCASTER AUTOMOTIVE

 

	
	 DEALER NAME

	 LANCASTERS AUTO SALES, INC.

	 LANDERS MCLARTY SUBARU

	 LANDMARK CDJ OF MONROE, LLC

	 LANDMARK MOTOR COMPANY

	 LANE 1 MOTORS

	 LANG CHEVROLET COMPANY

	 LANGDALE HONDA KIA OF

	 LANIGAN’S AUTO SALES

	 LARRY JAY IMPORTS, INC

	 LARRY ROESCH-CHRYSLER JEEP INC

	 LASCO FORD INC

	 LATIN MOTORS INTERNATIONAL LLC

	 LAWRENCEBURG CHEVROLET INC

	 LEBANON FORD LINCOLN

	 LEE’S AUTO SALES, INC

	 LEG MOTORS LLC

	 LEITH PREOWNED

	 LEXUS OF SARASOTA

	 LEXUS RIVER CENTER

	 LGE CORP

	 LIBERTY AUTO CITY INC

	 LIBERTY AUTO OUTLET INC

	 LIBERTY FORD SOLON, INC.

	 LIBERTY FORD, INC

	 LIBERTY MOTORS LLC

	 LIBERTY USED MOTORS INC

	 LIBERTYVILLE CHEVROLET LLC

	 LIPTON TOYOTA

	 LMN AUTO INC

	 LOCHMANDY AUTOS

	 LOKEY NISSAN

	 LONDOFF JOHNNY CHEVROLET INC

	 LONGSTREET AUTO

	 LONGWOOD KIA MITSUBISHI

	 LOU FUSZ MITSUBISHI ST. PETERS

	 LOU FUSZ MOTOR CO

	 LOUDON MOTORS, INC

	 LOVELADY MOTOR COMPANY INC

	 LUCKY CARS

	 LUCKY LINE MOTORS INC

	 LUXOR AUTOMOTIVE INC

	 LUXURY AUTO DEPOT

	 LUXURY AUTO LINE LLC

	 LUXURY CARS & FINANCIAL, INC.

	
	 DEALER NAME

	 LUXURY CARS OUTLET

	 LUXURY FLEET LEASING LLC

	 LUXURY IMPORTS AUTO SALES

	 LUXURY MOTOR CAR COMPANY

	 LYNN HINES USED CARS

	 LYNN LAYTON CHEVROLET

	 LYONS CHEVROLET BUICK GMC INC

	 M & M AUTO GROUP INC

	 M & M AUTO SUPER STORE

	 M & M AUTO WHOLESALERS, LLC

	 M & M AUTO, INC.

	 MA & PAS AUTO SALES & SERVICE

	 MACATAWA AUTO & FINANCE CO

	 MACHADO AUTO SELL LLC

	 MAGIC IMPORTS OF

	 MAGIC MOTORS CENTER

	 MAHER CHEVROLET INC

	 MAINLAND AUTO SALES INC

	 MAINSTREET AUTOMART LLC

	 MANASSAS AUTO TRUCK & TRACTOR

	 MANASSAS AUTOMOBILE GALLERY

	 MARANATHA AUTO

	 MARCH MOTORS INC.

	 MARIETTA AUTO MALL CENTER

	 MARK SWEENEY BUICK PONTIAC GMC

	 MARKAL MOTORS INC

	 MARKS AUTO SALES

	 MARLOZ OF HIGH POINT

	 MARSHALL FORD

	 MARTINS USED CARS INC

	 MASHALLAH IMPORTS LLC

	 MASTER CAR INTERNATIONAL, INC

	 MASTER CARS

	 MATHEWS BUDGET AUTO CENTER

	 MATHEWS FORD INC.

	 MATHEWS FORD OREGON, INC

	 MATIA MOTORS, INC

	 MATRIX AUTO SALES, INC.

	 MATT CASTRUCCI

	 MATTHEWS MOTORS INC.

	 MAXIE PRICE CHEVROLETS OLDS,

	 MAXIMUM DEALS, INC.

	 MAXKARS MOTORS

	 MAYSVILLE AUTO SALES

 

	
	 DEALER NAME

	 MC AUTO

	 MCABEE MOTORS

	 MCCLUSKY AUTOMOTIVE LLC

	 MCFARLAND CHEVROLET-BUICK, INC

	 MCGHEE AUTO SALES INC.

	 MCJ AUTO SALES OF CENTRAL FLOR

	 MCKENZIE MOTOR COMPANY, INC,

	 MCPHAILS AUTO SALES

	 MCVAY MOTORS, INC.

	 MEADE BROTHERS AUTO LLC

	 MECHANICSVILLE TOYOTA

	 MEDINA AUTO BROKERS

	 MEDINA AUTO BROKERS

	 MEDLIN MOTORS, INC.

	 MELRAY MOTORS CORP

	 MELROSE PARK AUTO MALL

	 MEMBERS SALES AND LEASING INC

	 MENTOR NISSAN

	 MERCEDES- BENZ OF BEDFORD

	 MERLIN AUTOS LLC

	 METRO USED CARS

	 MIA REPOS LLC

	 MIAMI AUTO SHOW LLC

	 MIAMI AUTO WHOLESALE

	 MIAMI CARS INTERNATIONAL INC

	 MICHAEL’S AUTO SALES CORP

	 MID AMERICA AUTO EXCHANGE INC

	 MID AMERICA AUTO GROUP

	 MID ATLANTIC AUTO SALES INC

	 MID RIVERS MOTORS

	 MIDDLE TENNESSEE AUTO MART LLC

	 MIDFIELD MOTOR COMPANY, INC.

	 MIDSTATE MOTORS

	 MID-TOWN MOTORS LLC

	 MIDWAY AUTO GROUP

	 MIDWAY MOTORS

	 MIDWEST AUTO STORE LLC

	 MIDWEST FINANCIAL SERVICES

	 MIDWEST MOTORS & TIRES

	 MIDWESTERN AUTO SALES, INC.

	 MIG CHRYSLER DODGE JEEP RAM

	 MIGENTE MOTORS INC

	 MIKE ANDERSON USED CAR SUPER

	 MIKE BASS FORD

	
	 DEALER NAME

	 MIKE CASTRUCCI FORD OF ALEX

	 MIKE CASTRUCCI FORD SALES

	 MIKE LANCE JEEPS LLC

	 MIKE PRUITT HONDA, INC

	 MIKES TRUCKS AND CARS

	 MILES AUTO SALES

	 MILESTONE MOTORS, L.L.C.

	 MILTON DODGE CHRYSLER JEEP

	 MILTON MARTIN HONDA

	 MINIVAN SOURCE, INC.

	 MINTON MOTOR CARS II LP

	 MIRA AUTO SALES LLC

	 MIRACLE CHRYSLER DODGE JEEP

	 MISSOURI MOTORS LLC

	 MITCHELL COUNTY FORD LLC

	 MITCHELL MOTORS

	 MJ AUTO SALES

	 MJ AUTO SALES

	 MNS AUTO LLC

	 MODERN CHEVROLET

	 MODERN CORP

	 MONROE DODGE/CHRYSLER INC.

	 MONZON AUTO SALES INC

	 MORNING STAR MOTORS

	 MORRIS IMPORTS LLC

	 MORRISVILLE AUTO SALES

	 MORROWS AUTO SALES

	 MOTOR CAR CONCEPTS II

	 MOTOR CARS HONDA

	 MOTORCARS

	 MOTORCARS TOYOTA

	 MOTORMART LLC

	 MOTORMAX OF GRAND RAPIDS

	 MOTORS DRIVEN INC

	 MOTORSPORTS UNLIMITED INC

	 MOTORVATION MOTOR CARS

	 MR DEALS AUTO SALES & SERVICE

	 MULLEN AUTO SALES LLC

	 MULLINAX FORD OF PALM BEACH

	 MURPHY AUTO CENTER OF

	 MURRAY’S USED CARS

	 MY CAR LLC

	 MYEZAUTOBROKER.COM LLC

	 MYLENBUSCH AUTO SOURCE LLC

 

	
	 DEALER NAME

	 N & D AUTO SALES, INC.

	 N T I

	 NALLEY HONDA

	 NAPLETON’S HYUNDAI

	 NAPLETONS NISSAN/NAPLETONS

	 NAPLETON’S RIVER OAKS CHRYSLER

	 NAPLETON’S RIVER OAKS KIA

	 NATIONAL ADVANCE CORP

	 NATIONAL ADVANCE CORP

	 NATIONAL AUTO CREDIT INC

	 NATIONAL AUTOMOTIVE, INC

	 NATIONAL CAR MART, INC

	 NATIONAL ROAD AUTOMOTIVE LLC

	 NATIONWIDE AUTOMOTIVE GROUP

	 NEIL HUFFMAN VW

	 NELSON AUTO SALES

	 NELSON MAZDA

	 NEUHOFF AUTO SALES

	 NEW CARLISLE CHRYSLER JEEP

	 NEW GENERATION MOTORS INC

	 NEWPORT AUTO GROUP

	 NEWPORT UNIVERSAL GROUP CORP

	 NEWTON’S AUTO SALES, INC.

	 NEXT CAR INC

	 NICE AUTO GROUP LLC

	 NICHOLAS DATA SERVICES, INC.

	 NICHOLS DODGE, INC.

	 NIMNICHT PONTIAC

	 NISSAN ON NICHOLASVILLE

	 NORTH ATLANTA AUTO SUPERSTORE

	 NORTH ATLANTA MOTORS LLC

	 NORTH BROTHERS FORD, INC

	 NORTHEND MOTORS INC

	 NORTHPOINTE AUTO SALES

	 NORTHTOWNE MOTORS

	 NORTHWEST MOTORS INC

	 NOURSE CHILLICOTHE

	 NUMBER ONE IN RADIO ALARMS INC

	 NUOVO INIZIO OF FLORIDA, INC.

	 O C WELCH FORD LINCOLN MERCURY

	 OAKES AUTO INC

	 OCEAN HONDA

	 O’CONNORS AUTO OUTLER

	 OFF LEASE FINANCIAL, INC.

	
	 DEALER NAME

	 OFFLEASE AUTOMART LLC

	 O’HARE MOTOR CARS

	 OHIO AUTO CREDIT

	 OHIO AUTO WAREHOUSE

	 OKOLONA MOTOR SALES

	 OLATHE FORD SALES, INC.

	 OLD SOUTH SALES INC.

	 OLDHAM MOTOR COMPANY LLC

	 OLYMPIC SALES & SERVICE

	 ON THE ROAD AGAIN, INC.

	 ON TRACK AUTO MALL, INC.

	 ONYX MOTORS

	 ORANGE PARK AUTO MALL

	 ORANGE PARK DODGE

	 ORLANDO AUTOS

	 ORLANDO HYUNDAI

	 OSCAR MOTORS CORPORATION

	 OVERFLOW MOTORS LLC

	 OXMOOR CHRYSLER DODGE JEEP RAM

	 OXMOOR FORD LINCOLN MERCURY

	 OXMOOR TOYOTA

	 P & G FINANCE & AUTO SALES

	 PACE CAR

	 PACE CHEVROLET BUICK GMC

	 PACE MOTOR COMPANY

	 PALM BAY FORD

	 PALM BAY MOTORS

	 PALM BEACH AUTO DIRECT

	 PALM CHEVROLET

	 PALMETTO 57 NISSAN

	 PALMETTO FORD

	 PALMETTO WHOLESALE MOTORS

	 PANAMA CITY AUTOMOTIVE

	 PAQUET AUTO SALES

	 PARADISE MOTOR SPORTS

	 PARAMOUNT AUTO

	 PARK AUTO MALL, INC

	 PARK AUTO PLAZA LLC

	 PARKS AUTOMOTIVE, INC

	 PARKWAY FORD, INC.

	 PARKWAY MITSUBISHI

	 PARKWAY MOTORS INC

	 PATRIOT AUTOMOTIVE LLC

	 PAUL CERAME KIA

 

	
	 DEALER NAME

	 PAUL CLARK ENTERPRISES INC

	 PAUL MILLER FORD, INC.

	 PAYLESS AUTO DEALS LLC

	 PAYLESS AUTO OF TULLAHOMA

	 PAYLESS CARS SALES GREENSBORO

	 PAYLESS MOTORS LLC

	 PCT ENTERPRISES OF FLORIDA LLC

	 PEGGY’S AUTO SALES

	 PELHAM’S AUTO SALES

	 PENSACOLA AUTO BROKERS, INC

	 PEREZ SALES & SERVICE, INC

	 PERFORMANCE CHEVROLET BMW

	 PERFORMANCE GMC OF

	 PERFORMANCE TOYOTA

	 PETE MOORE CHEVROLET, INC

	 PETE MOORE IMPORTS, INC

	 PETERS AUTO SALES, INC.

	 PG MOTORS LLC

	 PHILIP MOTORS INC

	 PHILLIPS BUICK PONTIAC GMC INC

	 PHOENIX MOTORS

	 PHOENIX SPECIALTY MOTORS CORP

	 PIEDMONT AUTO SALES INC

	 PILES CHEV-OLDS-PONT-BUICK

	 PINELLAS MOTORS INC

	 PINEVILLE IMPORTS

	 PLAINFIELD AUTO SALES, INC.

	 PLAINFIELD FAMILY AUTO & REPAI

	 PLATINA CARS AND TRUCKS INC

	 PLATTNER’S

	 PLAZA LINCOLN MERCURY

	 PLAZA PONTIAC BUICK GMC INC

	 POGUE CHEVROLET INC

	 PORT MOTORS

	 PORTAL AUTOMOTIVE INC

	 POWER PONTIAC GMC OLDSMOBILE

	 POWERBUY MOTORS

	 PRADO AUTO SALES

	 PREFERRED AUTO

	 PREMIER AUTO BROKERS, INC.

	 PREMIER AUTO EXCHANGE

	 PREMIER AUTO SALES

	 PREMIER AUTOS OF ALTON

	 PREMIER FORD LINCOLN MERCURY

	
	 DEALER NAME

	 PREMIER MAZDA/CDJ AUTOMOTIVE

	 PREMIERE CHEVROLET, INC.

	 PREMIUM AUTO BY RENT

	 PREMIUM MOTORS LLC

	 PREMIUM MOTORS OF FLORIDA LLC

	 PRESTIGE AUTO BROKERS

	 PRESTIGE AUTO EXCHANGE

	 PRESTIGE AUTO MALL

	 PRESTIGE AUTO SALES II INC

	 PRESTIGE MOTORS OF VIERA

	 PRESTON AUTO OUTLET

	 PRICE RIGHT STERLING HEIGHTS

	 PRICED RIGHT AUTO, INC.

	 PRICED RIGHT CARS, INC

	 PRIDE AUTO SALES

	 PRIME MOTORS INC

	 PRIME MOTORS, INC.

	 PROCAR

	 PROFESSIONAL AUTO SALES

	 PT AUTO WHOLESALE

	 QUALITY IMPORTS

	 QUALITY MOTORS LLC

	 R & B CAR COMPANY

	 R & Z AUTO SALES

	 R AND R MOTORS

	 R.K. CHEVROLET

	 RADER CAR CO INC

	 RAMOS AUTO LLC

	 RAMSEY MOTORS

	 RANKL & RIES MOTORCARS, INC

	 RAY CHEVROLET

	 RAY LAETHEM BUICK GMC INC

	 RAY PEARMAN LINCOLN MERCURY

	 RAY SKILLMAN CHEVROLET

	 RAY SKILLMAN EASTSIDE

	 RAY SKILLMAN FORD INC.

	 RAY SKILLMAN OLDSMOBILE AND

	 RAY SKILLMAN USED CAR

	 RAY SKILLMAN WESTSIDE

	 RC AUTO CREDIT

	 RE BARBER FORD INC

	 REAL BIZ AUTOMOTIVES

	 REALITY AUTO SALES INC

	 REGAL PONTIAC, INC.

 

	
	 DEALER NAME

	 REGIONAL WHOLESALE

	 REID’S AUTO CONNECTION

	 REIDSVILLE NISSAN INC

	 REINEKE FORD LINCOLN MERCURY

	 RELIABLE TRUCK SALES

	 RENEWIT CAR CARE

	 REVOLUTION MOTORS LLC

	 RICART FORD USED

	 RICE AUTO SALES

	 RICHARD KAY AUTOMOTIVE

	 RICK CASE CARS INC

	 RICK CASE MOTORS, INC.

	 RICK HENDRICK CHEVROLET

	 RICK HILL NISSAN INC

	 RICK MATTHEWS BUICK PONTIAC

	 RICKS AUTO SALES

	 RIDE TIME, INC.

	 RIGHT HOUR AUTO SALES INC

	 RIGHTWAY AUTOMOTIVE CREDIT

	 RIGHTWAY AUTOMOTIVE CREDIT

	 RIO AUTO GROUP

	 RIOS MOTORS

	 RIVER CITY AUTO SALES INC

	 RIVERCHASE KIA

	 RIVERGATE TOYOTA

	 RIVERSIDE MOTORS, INC

	 RIVERVIEW AUTO & WATERCRAFT

	 RIVIERA AUTO SALES SOUTH, INC.

	 RJ’S AUTO SALES

	 RML HUNTSVILLE AL AUTOMOTIVE

	 ROAD MASTER AUTO SALES LLC

	 ROB PARTELO’S WINNERS

	 ROBERT-ROBINSON CHEVROLET

	 ROBERTS COMPANY MOTOR MART LLC

	 ROCK ROAD AUTO PLAZA

	 ROGER WILLIAMS AUTO SALES

	 ROGER WILSON MOTORS INC

	 ROSE AUTOMOTIVE INC

	 ROSE CITY MOTORS

	 ROSE CITY MOTORS

	 ROSE CITY MOTORS 2

	 ROSEDALE AUTO SALES INC

	 ROSEN HYUNDAI OF ALGONQUIN LLC

	 ROSEN MAZDA

	
	 DEALER NAME

	 ROSEN MAZDA OF LAKE VILLA

	 ROSEN NISSAN

	 ROSWELL MITSUBISHI

	 ROUEN CHRYSLER DODGE JEEP INC

	 ROUEN MOTORWORKS LTD

	 ROUTE 4 BUDGET AUTO

	 ROY O’BRIEN, INC

	 ROYAL AUTO SALES

	 ROYAL AUTOTEC INC

	 ROYAL FAMILY MOTORS INC

	 RP AUTOMOTIVE LLC

	 RPM AUTO SALES

	 RT 177 AUTO SALES INC

	 RUSSELL AUTO SALES

	 S ANDREWS AUTO SALES INC

	 S S & M AUTOMOTIVE

	 S S AUTO INC

	 SAM GALLOWAY FORD INC.

	 SANDY’S AUTO SALES LLC

	 SANSING CHEVROLET, INC

	 SAULS MOTOR COMPANY, INC.

	 SAVANNAH AUTO

	 SAVANNAH AUTOMOTIVE GROUP

	 SAVANNAH SPORTS AND IMPORTS

	 SAVANNAH TOYOTA & SCION

	 SCANLON IMPORTS, INC.

	 SCHAUMBURG HYUNDAI

	 SELECT AUTO

	 SELECT AUTO NETWORK LLC

	 SELECT AUTO SALES

	 SELECT MOTORS OF TAMPA INC.

	 SERRA AUTOMAX - DEACTIVATED

	 SEVERITY MOTORSPORTS INC

	 SHAD MITSUBISHI

	 SHAFER PREFERRED MOTORS INC

	 SHARP CARS OF INDY

	 SHAWNEE MOTORS GROUP

	 SHEEHY FORD INC

	 SHEEHY GLEN BURNIE INC.

	 SHELBYVILLE CHRYSLER PRODUCTS

	 SHERDAN ENTERPRISES LLC

	 SHERMAN DODGE

	 SHERWOOD OF SALISBURY INC

	 SHOOK AUTO INC

 

	
	 DEALER NAME

	 SHOW ME AUTO MALL INC

	 SHOWCASE AUTOS, INC

	 SHUTT ENTERPRISES INC

	 SIGN & DRIVE AUTO SALES LLC

	 SIGN & DRIVE MOTORS LLC

	 SIGNATURE MOTORS USA LLC

	 SIMON SAYS ETC CORP

	 SIMS BUICK GMC NISSAN

	 SINA AUTO SALES, INC.

	 SINCLAIR BUICK GMC TRUCK INC

	 SINCLAIR DAVE LINCOLN MERCURY

	 SMH AUTO

	 SMITH MOTORS LLC

	 SOUTH 71 AUTO SALES

	 SOUTH BEACH MOTOR CARS

	 SOUTH CHARLOTTE PREOWNED AUTO

	 SOUTH I-75 CHRYSLER DODGE JEEP

	 SOUTH MIAMI FIAT

	 SOUTH MOTORS HONDA

	 SOUTHEAST JEEP EAGLE

	 SOUTHERN CARS

	 SOUTHERN CARS

	 SOUTHERN CHEVROLET

	 SOUTHERN DODGE CHRY JP RAM @ N

	 SOUTHERN MOTOR COMPANY

	 SOUTHERN STAR AUTOMOTIVE

	 SOUTHERN TRUST AUTO GROUP

	 SOUTHERN TRUST AUTO SALES

	 SOUTHFIELD JEEP-EAGLE, INC.

	 SOUTHGATE FORD

	 SOUTHPORT MOTORS

	 SOUTHTOWN MOTORS

	 SPACE & ROCKET AUTO SALES

	 SPIRIT CHEVROLET-BUICK INC.

	 SPITZER DODGE

	 SPITZER KIA

	 SPITZER MOTOR CITY

	 SPORTS AND IMPORTS, INC.

	 SRQ AUTO LLC

	 STANFIELD AUTO SALES

	 STAR MOTORS

	 STARK AUTO GROUP

	 STARRS CARS AND TRUCKS, INC

	 STATE AUT GROUP LLC

	
	 DEALER NAME

	 STATELINE CHRYSLER DODGE JEEP

	 STEELY LEASE SALES

	 STEPHEN A FINN AUTO BROKER

	 STERLING AUTO SALES

	 STEVE AUSTINS AUTO GROUP INC

	 STEVE RAYMAN CHEVROLET, LLC

	 STEWART AUTO GROUP OF

	 STEWART MOTORS

	 STINGRAY CHEVROLET BARTOW LLC

	 STL CAR CREDIT

	 STOKES BROWN TOYOTA SCION

	 STOKES BROWN TOYOTA SCION

	 STOKES HONDA CARS OF BEAUFORT

	 STOKES KIA

	 STOKES USED CAR CENTER

	 STONE MOUNTAIN NISSAN

	 STOUT SALES

	 STRICKLAND AUTOMOTIVE INC

	 STYKEMAIN CHEVROLET PONTIAC

	 SUBARU CONCORD

	 SUBARU OF DAYTON

	 SUBARU OF KENNESAW LLC

	 SUBARU OF MCDONOUGH, LLC

	 SUBARU OF WICHITA LLC

	 SUBURBAN AUTO SALES

	 SUBURBAN CHRYSLER JEEP DODGE

	 SUFFIELD MOTORS

	 SUMMIT AUTOPLEX LLC

	 SUMMIT PLACE KIA

	 SUMMIT PLACE KIA MT. CLEMENS

	 SUMMIT PRE-OWNED OF RALEIGH

	 SUMTER CARS & TRUCKS

	 SUN HONDA

	 SUN TOYOTA

	 SUNNY FLORIDA MOTORS, INC.

	 SUNRAY AUTO SALES INC

	 SUNRISE AUTOMOTIVE

	 SUNRISE CHEVROLET

	 SUNSET MOTORS

	 SUNSHINE AUTO BROKERS INC

	 SUNSTATE FORD

	 SUNTRUP NISSAN VOLKSWAGEN

	 SUPER AUTO SALES

	 SUPER AUTOS MIAMI

 

	
	 DEALER NAME

	 SUPER DEAL AUTO SALES LLC

	 SUPERCARS OF CAROLINAS LLC

	 SUPERIOR HONDA

	 SUPERIOR KIA

	 SUPERIOR PONTIAC BUICK GMC, INC

	 SUPREME CARRIAGE LLC

	 SUPREME MOTORS OF NASHVILLE

	 SUSAN SCHEIN CHRYSLER PLYMOUTH

	 SUSKI CHEVROLET BUICK INC

	 SUTHERLAND CHEVROLET INC

	 SUTHERLIN NISSAN OF FT. MYERS

	 SUZUKI OF NASHVILLE

	 SVG MOTORS LLC

	 SW PREMIER MOTOR GROUP INC

	 SWEENEY BUICK PONTIAC GMC

	 TAMERON AUTOMOTIVE GROUP

	 TAMIAMI FORD, INC.

	 TAMPA HONDA

	 TAMPABAYAUTOS.NET

	 TARGET AUTOMOTIVE

	 TAYLOR AUTO SALES INC.

	 TAYLOR MORGAN INC

	 TAYLOR’S AUTO SALES

	 TEAM AUTO INC

	 TEAM AUTOMOTIVE

	 TEAM NISSAN OF MARIETTA

	 TED CIANOS USED CAR CENTER

	 TENNESSEE AUTO SALES

	 TENNESSEE AUTOPLEX, LLC

	 TERRE HAUTE AUTO AND EQUIPMENT

	 TERRY CULLEN CHEVROLET

	 TERRY LABONTE CHEVROLET

	 TERRY LEE HONDA

	 THE 3445 CAR STORE, INC.

	 THE AUTO BROKER

	 THE AUTO GROUP LLC

	 THE AUTO LIVERY

	 THE AUTO PARK INC

	 THE AUTO STORE

	 THE AUTO STORE

	 THE AUTOBLOCK

	 THE CAR CABANA OF

	 THE CAR CENTER

	 THE CAR COMPANY SUZUKI

	
	 DEALER NAME

	 THE CAR CONNECTION, INC.

	 THE CAR EXCHANGE

	 THE CAR SHOPPE LLC

	 THE CAR STORE

	 THE LUXURY AUTOHAUS INC.

	 THE MINIVAN STORE

	 THE MONTGOMERY GROUP LLC

	 THE REPO STORE

	 THOMAS & SON INC.

	 THOMAS OF CAIRO, CHEV, PONT

	 THOMASVILLE TOYOTA

	 THORNTON CHEVROLET, INC

	 THORNTON ROAD HYUNDAI

	 THOROUGHBRED FORD INC

	 THRIFTY OF GRAND RAPIDS

	 TIFFIN FORD LINCOLN MERCURY

	 TILLMAN AUTO LLC

	 TIM FRENCH SUPER STORES, LLC

	 TIM SHORT CHEVY BUICK GMC OF

	 TIM TOMLIN AUTOMOTIVE GROUP

	 TINCHER AUTO GROUP

	 TINPUSHER LLC

	 TKP AUTO SALES INC

	 TNT AUTO SALES INC

	 TOM EDWARDS, INC

	 TOM GILL CHEVROLET

	 TOM HOLZER FORD

	 TOM STENHOUWER AUTO SALES INC

	 TOM WOOD FORD

	 TOMLINSON MOTOR COMPANY OF

	 TONY ON WHEELS INC

	 TOP CHOICE AUTO

	 TOP GUN AUTO SALES LLC

	 TOPLINE CARS CORP

	 TOWN & COUNTRY AUTO SALES, LLC

	 TOWN & COUNTRY FORD, INC.

	 TOWN & COUNTRY FORD, INC.

	 TOWNE EAST AUTO

	 TOYOTA OF GASTONIA

	 TOYOTA OF HOLLYWOOD

	 TOYOTA OF LOUISVILLE, INC.

	 TOYOTA OF MCDONOUGH

	 TOYOTA OF MUNCIE

	 TOYOTA OF TAMPA BAY

 

	
	 DEALER NAME

	 TOYOTA ON NICHOLASVILLE

	 TOYOTA WEST/SCION WEST

	 TRI STATE USED AUTO SALES

	 TRIAD AUTOPLEX

	 TRI-CITY AUTO MART

	 TRINITY AUTOMOTIVE

	 TRIPLE C AUTO INC

	 TRIPLE D MOTORS LLC

	 TROPICAL AUTO OUTLET

	 TROPICAL AUTO SALES

	 TROY FORD INC

	 TRUCK TOWN INC

	 TRUSSVILLE WHOLESALE AUTOS

	 TRUST US AUTO SALES LLC

	 TRYON AUTO MALL

	 TWIN CITY CARS INC

	 TYLER AUTOMOTIVE GROUP INC

	 U.S. AUTO GROUP, INC.

	 U-DRIVE AUTO LLC

	 ULTIMATE AUTO DEALS INC

	 ULTIMATE IMAGE AUTO, INC

	 UNITED AUTO SALES

	 UNITED LUXURY MOTORS LLC

	 UNITED VEHICLE SALES

	 UNIVERSAL AUTO PLAZA

	 UNIVERSAL AUTO PLAZA LLC

	 UNIVERSITY HYUNDAI OF DECATUR

	 UNIVERSITY KIA

	 UNLIMITED AUTOMOTIVE

	 UNLIMITED MOTORS

	 UNLIMITED MOTORS

	 UNLIMITED MOTORS

	 UPPER MARLBORO FORD LLC

	 UPSTATE LIL BOYZ TOYZ LLC

	 US 1 CHRYSLER DODGE JEEP

	 USA AUTO & LENDING INC

	 USA MOTORCARS

	 USED CAR FACTORY INC

	 USED CAR SUPERMARKET

	 V & S AUTO SALES LLC

	 VA CARS INC

	 VADEN NISSAN, INC.

	 VANN YORK BARGAIN CARS LLC

	 VANN YORK PONTIAC BUICK GMC

	
	 DEALER NAME

	 VANN YORK PONTIAC, INC.

	 VANN YORK TOYOTA, INC

	 VANTAGE MOTORS LLC

	 VARSITY LINCOLN MERCURY

	 VEHICLES 4 SALES, INC.

	 VELOCITY MOTORS INC

	 VERACITY MOTOR COMPANY LLC

	 VESTAVIA HILLS AUTOMOTIVE

	 VICTORIA MOTORS, LLC

	 VICTORY AUTO EXPRESS INC

	 VICTORY AUTO INC

	 VICTORY CHEVROLET BUICK

	 VICTORY CHEVROLET LLC

	 VICTORY MOTOR SALES INC

	 VILLAGE AUTOMOTIVE

	 VIN DEVERS, INC

	 VINCE WHIBBS PONTIAC-GMC

	 VININGS ENTERPRISES INC

	 VINUP MOTORS

	 VIP AUTO ENTERPRISES INC

	 VIP AUTO GROUP, INC.

	 VIP ONE IMPORTS INC

	 VIRGINA MOTOR CO.

	 VOGUE MOTOR CO INC

	 VOLUSIA AUTO SALES

	 VOLVO OF FT. MYERS

	 VULCAN MOTORS LLC

	 W & S AUTO CENTER INC

	 WABASH AUTO CARE INC

	 WADE FORD INC

	 WAGNER SUBARU

	 WALDEN AUTOMOTIVE ENTERPRISES

	 WALDROP MOTORS INC

	 WALKER FORD CO., INC.

	 WALT SWEENEY FORD, INC

	 WALTERS AUTO SALES AND RENTALS

	 WALT’S LIVE OAK FORD

	 WANTED WHEELS INC

	 WASHINGTON BLVD MOTORS

	 WAYNE AKERS FORD INC.

	 WEB AUTO BROKERS

	 WEBBER AUTOMOTIVE LLC

	 WEINE AUTO SALES EAST

	 WEINLE AUTO SALES

 

	
	 DEALER NAME

	 WEST CLAY MOTOR COMPANY LLC

	 WEST HIGH AUTO LLC

	 WEST KENDALL TOYOTA

	 WEST MAIN MOTORS

	 WEST SIDE TOYOTA

	 WESTSIDE MOTOR CO

	 WHEELS & DEALS AUTO SALES

	 WHEELS & DEALS AUTO SALES OF

	 WHEELS AUTO SALES

	 WHITE FORD CO., INC.

	 WHITEWATER MOTOR COMPANY INC

	 WHOLESALE AUTO BROKERS INC

	 WHOLESALE, INC

	 WILDCAT AUTO SALES

	 WILDWOOD MOTORS

	 WILLS MOTOR SALES

	 WINDSOR AUTO SALES

	 WINTER PARK AUTO EXCHANGE INC

	 WMD MOTORS INC

	 WOODBRIDGE MOTORS, INC.

	 WOODY ANDERSON FORD

	 WOODY SANDER FORD, INC.

	 WORLD AUTO NETWORK INC

	 WORLD AUTO, INC.

	 WORLD CAR CENTER & FINANCING

	 WORLDWIDE MOTORS LLC

	 WORLEY AUTO SALES

	 WOW CAR COMPANY

	 WRIGHT’S AUTO SALES

	 WWW.GETAUCTIONCARS.COM

	 WYRICK AUTO SALES

	 XCITING AUTO SALES LLC

	 XL1 MOTORSPORTS, INC

	 XTREME MOTORS INC

	 YARK AUTOMOTIVE GROUP, INC

	 YERTON LEASING & AUTO SALES

	 YES AUTO SALES INC

	 YES AUTOMOTIVE LLC

	 YESHUA AUTO SALES LLC

	 YOU SELECT AUTO SALES LLC

	 YOUR DEAL AUTOMOTIVE

	 YOUR KAR CO INC

	 ZEIGLER CHEVROLET LLC

	 ZOMBIE JOHNS KILLER DEALS LLCExhibit 10.1

 

EXECUTION VERSION

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

ASSET PURCHASE AGREEMENT

 

BETWEEN

 

NOVEN THERAPEUTICS, LLC

 

AND

 

ANI PHARMACEUTICALS, INC.

 

 

 

Dated as of July 1, 2014

 

 

 

    	 

    	 

    

  

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

TABLE OF CONTENTS

 

	 	 	 	 	Page
	Section 1	 	DEFINITIONS	 	1
	 	 	 	 	 
	Section 2	 	THE SALE	 	5
	 	 	 	 	 
	2.1	 	Sale and Purchase; Assumption of Certain Liabilities	 	5
	2.2	 	Consideration; Allocation of Consideration	 	6
	2.3	 	Closing	 	7
	2.4	 	Transfer of Purchased Assets; Cooperation	 	8
	 	 	 	 	 
	Section 3	 	REPRESENTATIONS AND WARRANTIES OF THE SELLER	 	9
	 	 	 	 	 
	3.1	 	Organization	 	9
	3.2	 	Power and Authorization	 	9
	3.3	 	Authorization of Governmental Authorities	 	9
	3.4	 	Noncontravention	 	9
	3.5	 	Encumbrances	 	9
	3.6	 	Purchased Assets	 	9
	3.7	 	Intellectual Property	 	10
	3.8	 	Legal Compliance	 	10
	3.9	 	Litigation	 	10
	3.10	 	Ordinary Course	 	11
	3.11	 	AMP	 	11
	3.12	 	No Brokers	 	11
	3.13	 	Solvency	 	11
	3.14	 	No Other Representations or Warranties; Schedules	 	11
	 	 	 	 	 
	Section 4	 	REPRESENTATIONS AND WARRANTIES OF THE BUYER	 	11
	 	 	 	 	 
	4.1	 	Organization	 	11
	4.2	 	Power and Authorization	 	12
	4.3	 	Authorization of Governmental Authorities	 	12
	4.4	 	No Brokers	 	12
	4.5	 	Noncontravention	 	12
	4.6	 	Financial Capability	 	12
	4.7	 	Solvency	 	12
	 	 	 	 	 
	Section 5	 	COVENANTS AND AGREEMENTS	 	12
	 	 	 	 	 
	5.1	 	Expenses	 	12
	5.2	 	Payment and Discharge of Liabilities	 	13
	5.3	 	Further Assurances	 	13
	5.4	 	Public Announcements	 	13
	5.5	 	Customer Notifications	 	13
	5.6	 	NDC Numbers	 	13
	5.7	 	Access After Closing	 	13
	5.8	 	Inventory	 	14
	5.9	 	Regulatory Matters	 	14
	5.10	 	Reporting of and Response to Adverse Drug Experience Reports, Medical Inquiries and Product Complaints	 	14
	5.11	 	Rebates; Returns	 	15
	5.12	 	Post-Closing Cooperation	 	15
	5.13	 	Buyer’s Due Diligence Investigation	 	16

 

    	i

    	 

    

  

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

TABLE OF CONTENTS

(continued)

 

	 	 	 	 	Page
	Section 6	 	INTENTIONALLY OMITTED	 	16
	 	 	 	 	 
	Section 7	 	INTENTIONALLY OMITTED	 	16
	 	 	 	 	 
	Section 8	 	INDEMNIFICATION	 	16
	 	 	 	 	 
	8.1	 	Indemnification by the Seller	 	17
	8.2	 	Indemnification by the Buyer	 	17
	8.3	 	Limits	 	17
	8.4	 	Time for Claims	 	18
	8.5	 	Procedure	 	18
	8.6	 	Exclusive Remedy; Release	 	18
	8.7	 	Limits on Indemnification	 	19
	8.8	 	Treatment of Indemnification Payment by Seller	 	19
	8.9	 	Consequential Damages	 	19
	 	 	 	 	 
	Section 9	 	CONFIDENTIALITY	 	19
	 	 	 	 	 
	9.1	 	General	 	19
	9.2	 	Exceptions	 	20
	9.3	 	Permitted Disclosures	 	20
	9.4	 	Confidential Terms	 	20
	9.5	 	Equitable Remedies	 	20
	 	 	 	 	 
	Section 10	 	DISPUTE RESOLUTION	 	20
	 	 	 	 	 
	10.1	 	Jurisdiction; Venue; Service of Process	 	20
	 	 	 	 	 
	Section 11	 	MISCELLANEOUS	 	21
	 	 	 	 	 
	11.1	 	Notices	 	21
	11.2	 	Amendment; Waiver	 	22
	11.3	 	Entire Agreement	 	22
	11.4	 	Governing Law	 	22
	11.5	 	Binding Effect; No Assignment; No Third-Party Beneficiaries	 	22
	11.6	 	Section Headings; Construction; Interpretation	 	23
	11.7	 	Counterparts	 	23
	11.8	 	Severability	 	23
	11.9	 	Rules of Construction	 	23
	11.10	 	Bulk Sales Laws	 	23
	11.11	 	Independent Contractor	 	23
	11.12	 	No Implied Waivers	 	23

 

	SCHEDULES	 	 
	Schedule I	-	Lithobid® Products
	Schedule II	-	Lithobid® Marks
	Schedule 2.1(a)(iv)	-	Worldwide Web Addresses and Domains
	Schedule 2.2	-	Allocation Schedule
	Schedule 3.3	-	Governmental Authorizations
	Schedule 3.4(a)	-	Noncontravention
	Schedule 3.4(b)	-	Consents

 

    	ii

    	 

    

  

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

TABLE OF CONTENTS

(continued)

 

Page

 

	Schedule 3.5	-	Encumbrances
	Schedule 3.7(b)	-	Intellectual Property Registrations
	Schedule 3.8(a)	-	Regulatory Matters
	Schedule 3.8(b)	-	Recalls, Etc.
	Schedule 3.8(c)	-	FDA Correspondence
	Schedule 3.9	-	Litigation
	Schedule 3.10	-	Ordinary Course
	Schedule 3.11	-	AMP
	Schedule 5.5	-	Customer Notification
	 	 	 
	EXHIBITS	 	 
	Exhibit A	-	Form of Bill of Sale
	Exhibit B	-	Form of Assignment and Assumption Agreement
	Exhibit C	-	Form of Assignment of Trademark Rights
	Exhibit D	-	Joint Public Statement
	Exhibit E	-	Transfer Letter
	Exhibit F	-	Supply Agreement Termination Letter
	Exhibit G	-	Buyer’s Acceptance Letter
	Exhibit H	-	Customer Notification Letter

 

    	iii

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

ASSET PURCHASE
AGREEMENT

 

This ASSET PURCHASE AGREEMENT (this “Agreement”)
is entered into as of July 1, 2014 (the “Closing Date”), by and between Noven Therapeutics, LLC, a Delaware
limited liability company formerly known as JDS Pharmaceuticals, LLC (the “Seller”) and ANI Pharmaceuticals,
Inc., a Delaware corporation (the “Buyer”). The Seller and the Buyer are referred to hereinafter individually
as a “Party” and collectively as the “Parties.”

 

RECITALS

 

A.           The
Seller is engaged in the promotion, distribution, marketing, and sale of the Lithobid Products (the “Business”).

 

B.           Pursuant
to the terms of that certain Manufacturing and Supply Agreement, dated December 6, 2007, between Seller and ANIP Acquisition Company,
a wholly owned subsidiary of Buyer (“ANIP Acquisition”), ANIP Acquisition is the current manufacturer of the
Lithobid Products (the “Supply Agreement”).

 

C.           Buyer
desires to purchase from Seller and Seller desires to sell to Buyer, the Purchased Assets for the Consideration and upon the terms
and conditions set forth herein (the “Sale”), and the Board of Directors of each of the Seller and the Buyer
has approved the consummation of the Sale and the transactions set forth herein.

 

In consideration of the mutual representations,
warranties and covenants contained herein, the Parties hereto agree as follows:

 

Section
1     DEFINITIONS

 

1.1           “Act”
means the Federal Food, Drug and Cosmetic Act, as amended, and the regulations promulgated thereunder from time to time.

 

1.2           “Additional
Payment” has the meaning set forth in Section 2.2(b) below.

 

1.3           “Affiliate”
means any person or legal entity controlling, controlled by or under common control with the person with respect to whom such status
is at issue and shall include, without limitation, any corporation fifty percent (50%) or more of the voting power of which (or
other comparable ownership interest for an entity other than a corporation) is owned, directly or indirectly, by the person with
respect to whom such status is at issue or any corporation, person or entity which owns fifty percent (50%) of more of such voting
power of the person with respect to whom such status is at issue.

 

1.4           “Agreement”
has the meaning set forth in the preamble above.

 

1.5           “Allocation
Schedule” has the meaning set forth in Section 2.2(c) below.

 

1.6           “AMP”
has the meaning set forth in Section 3.11 below.

 

1.7           “Ancillary
Agreements” has the meaning set forth in Section 2.3(a) below.

 

1.8           “ANIP
Acquisition” has the meaning set forth in the recitals above.

 

1.9           “API”
means the active pharmaceutical ingredient or pharmaceutically active compound Lithium Carbonate for use in the Lithobid Product.

 

    	 

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

1.10         “Assumed
Liabilities” has the meaning set forth in Section 2.1(c) below.

 

1.11         “Books
and Records” means the Marketing Materials and Data, and all of the following, to the extent solely relating to the Lithobid
Products or the Business and to the extent owned by Seller as of the Closing Date: all documents, if any, relating to the calculation
of baseline AMP received by Seller from Solvay (but excluding any proprietary methodology documents created by Seller or any of
Seller’s Affiliates with respect to the calculation of baseline AMP); all documents, if any, relating to NonFAMP-Eligible
Transactions from October 1, 2013 through the Closing Date; vendor lists and audits; batch records; change control reports; all
information relating to medical safety, including complaints and adverse drug event histories and files for the Lithobid Products;
copies of all filings (and supporting documentation and correspondence) with Regulatory Authorities, including, but not limited
to, the NDA for the Lithobid Products, as well as the Supplement; component and labeling purchasing specifications; quality assurance/control
data; and customer lists (if any).

 

1.12         “Bulk
Sales Laws” means the Laws of any jurisdiction relating to bulk sales that are applicable to the sale of the Purchased
Assets by Seller hereunder.

 

1.13         “Business”
has the meaning set forth in the recitals above.

 

1.14         “Business
Day” means any day other than a Saturday, Sunday or another day on which commercial banks in New York, New York are authorized
or required by law to close.

 

1.15         “Buyer”
has the meaning set forth in the preamble above.

 

1.16         “Buyer
Indemnified Party” has the meaning set forth in Section 8.1 below.

 

1.17         “Buyer’s
Acceptance Letter” has the meaning set forth in Section 2.3(b)(iii) below.

 

1.18         “Cap”
has the meaning set forth in Section 8.3(a) below.

 

1.19         “Closing”
has the meaning set forth in Section 2.3 below.

 

1.20         “Closing
Date” has the meaning set forth in the preamble.

 

1.21         “Closing
Payment” has the meaning set forth in Section 2.3(b)(i) below.

 

1.22         “Confidential
Information” has the meaning set forth in Section 9.1 below.

 

1.23         “Consideration”
has the meaning set forth in Section 2.2(b) below.

 

1.24         “Disclosing
Party” has the meaning set forth in Section 9.1 below.

 

1.25         “Dollar,”
“Dollars” and the symbol “$” each means lawful money of the United States of America.

 

1.26         “Excluded
Assets” has the meaning set forth in Section 2.1(b) below.

 

1.27         “FDA”
means the Food and Drug Administration or any successor agency thereof.

 

1.28         “FDA
Review” means the FDA’s review of the Supplement.

 

1.29         “Finished
Lithobid Product Inventory” has the meaning set forth in Section 2.1(b) below.

 

1.30         “Fundamental
Representations” has the meaning set forth in Section 8.4(a) below.

 

    	2

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

1.31         “Indemnified
Parties” means (i) with respect to claims arising under Section 8.1, the Buyer Indemnified Parties,
and (ii) with respect to claims arising under Section 8.2, the Seller Indemnified Parties.

 

1.32         “Indemnifying
Party” means (i) with respect to claims arising under Section 8.1, the Seller, and (ii) with respect
to claims arising under Section 8.2, the Buyer.

 

1.33         “Intellectual
Property Rights” means any and all of the following intellectual property rights owned by the Seller or its Affiliates
to the extent primarily used in the formulation, manufacture, packaging, promotion, distribution, marketing, and sale of the Lithobid
Products: (i) patents, patent applications (filed and unified), invention disclosures and invention assignments; (ii) trademarks,
trade names, trade dress, logos, slogans, rights of publicity, service marks and service names; (iii) copyrights and other
works; (iv) worldwide web addresses and domain names; (v) Know-How; (vi) Trade Secrets; (vii) all applications,
registrations, or common law or unregistered rights relating to any of the foregoing; and (viii) all rights to obtain renewals,
continuations, divisions or other extensions of legal protections pertaining to any of the foregoing. For clarity and for all purposes
under this Agreement, the name “Noven” and all trademarks and other intellectual property rights related thereto
are not Intellectual Property Rights.

 

1.34         “Inventory”
means all work-in-process, printed packaging components, raw materials, including API, and inventories of Finished Lithobid Product
Inventory that is owned by Seller.

 

1.35         “Know-How”
means all proprietary methods, processes, techniques, compositions, technology, information, data, results of tests, studies, statistical
and other analyses and expertise, whether patented or unpatented, in each case to the extent related solely to the Lithobid Products,
owned by the Seller or any Affiliate of the Seller which are, used solely in the formulation, manufacture or marketing of the Lithobid
Products, including, without limitation, pharmacology, toxicology, drug stability, manufacturing and formulation methodologies
and techniques, clinical and non-clinical safety and efficacy studies, marketing studies and absorption, excretion and metabolism
studies, quality control and quality assurance processes, and shall include, without limitation, all tangible manifestations thereof.

 

1.36         “Knowledge”
means, with respect to the Seller and with respect to any particular matter, the actual knowledge of Jeffrey Mihm, the Chief Administrative
Officer and General Counsel of Seller or Bruce Friedman, Vice President of the Seller and the knowledge each has or would have
after inquiry to his direct reports who have responsibility for and are likely to have knowledge of the matter in question.

 

1.37         “Law”
means all applicable federal, state and local laws, statutes or ordinances, including, without limitation, (i) the Act and
(ii) all regulations, rules, or published guidelines or pronouncements having the effect of law promulgated by any Regulatory
Authority.

 

1.38         “Liability”
means any liability (whether known or unknown, asserted or unasserted, absolute or contingent, accrued or unaccrued, liquidated
or unliquidated, and due or to become due), including any liability for Taxes.

 

1.39         “Lithobid
Marks” means the trademarks listed on Schedule II hereto.

 

1.40         “Lithobid
Products” means the specific products listed on Schedule I hereto.

 

1.41         “Losses”
has the meaning set forth in Section 8.1 below.

 

1.42         “Marketing
Materials and Data” means all of the following, to the extent solely relating to the Lithobid Products and to the extent
owned by Seller and in Seller’s possession: physician lists, customer lists, sales force training materials, market research
materials, advertising and promotional materials and records of sales and cost data for the twelve (12) months ended April 30,
2014.

 

    	3

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

1.43         “Material
Adverse Effect” means (i) with respect to any Person, a material adverse effect on the assets, financial condition,
or results of operations of such Person and its subsidiaries, taken as a whole, and (ii) with respect to the Business, a material
adverse effect on the Business taken as a whole, provided that in no event will any of the following, individually or in the aggregate,
be deemed to constitute, nor shall any of the following be taken into account in determining whether there has been, or will be,
a Material Adverse Effect with respect to such Person, or with respect to the Business: (A) any change in general economic
or financial market conditions, (B) any change in the general state of the industry in which such Person or the Business,
as applicable, operates, (C) any act of terrorism or war, or (D) the announcement of the execution of this Agreement
or the transactions contemplated hereby except to the extent any of the events in clauses (A) - (D) affects
such Person or the Business in a disproportionate manner to other Persons or products in the industry.

 

1.44         “NDA”
means New Drug Application 18-027.

 

1.45         “NDC”
has the meaning set forth in Section 5.6 below.

 

1.46         “NonFAMP-Eligible
Transactions” means those transactions relating to the Lithobid Products that are used to calculate the Non-Federal Average
Manufacturer Price as defined by Veteran’s Health Care Act of 1992.

 

1.47         “Party”
or “Parties” has the meaning set forth in the preamble above.

 

1.48         “Permitted
Encumbrances” means (i) encumbrances for Taxes not yet due and payable or being contested in good faith for which
adequate reserves have been established; and (ii) statutory and contractual encumbrances of landlords, carriers, warehousemen,
mechanics, materialmen, suppliers and repairmen, and other like encumbrances, incurred in the ordinary course of business and not
yet delinquent or being contested in good faith.

 

1.49         “Person”
means an individual, a corporation, a general partnership, a limited partnership, a limited liability company, a limited liability
partnership, an association, a trust or any other entity or organization, including a governmental authority.

 

1.50         “Product
Approval” means with respect to each Lithobid Product, the NDA set forth opposite the name of such Lithobid Product on
Schedule I hereto, together with the Supplement.

 

1.51         “Product
Technology” means the Intellectual Property Rights, manufacturing technology, and trade secrets, including, but not limited
to, the Know-How, that is owned or used by the Seller or its Affiliates and is necessary for the formulation, manufacture, packaging,
release testing and stability and shelf life determination of the Lithobid Products, including, but not limited to, specifications
and test methods, manufacturing and packaging instructions, master formula, validation reports (process, analytical methods and
cleaning), stability data and analytical methods, but excluding any common industry practice, process or procedure used or usable
in the manufacture of pharmaceutical products.

 

1.52         “Purchased
Assets” has the meaning set forth in Section 2.1(a) below.

 

1.53         “Reasonable
Commercial Efforts” means, with respect to a particular result, such efforts as a reasonably prudent Person desirous
of achieving such result would use in similar circumstances; provided that the applicable Party shall be required to expend only
such resources to achieve such result as are commercially reasonable in similar circumstances.

 

1.54         “Receiving
Party” has the meaning set forth in Section 9.1 below.

 

1.55         “Regulatory
Authority” means any governmental or regulatory body, court, agency, commission, official, or arbitrator, including,
without limitation, the FDA.

 

    	4

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

1.56         “Retained
Liabilities” has the meaning set forth in Section 2.1(d) below.

 

1.57         “Sale”
has the meaning set forth in the recitals above.

 

1.58         “Seller”
has the meaning set forth in the preamble above.

 

1.59         “Seller
Indemnified Party” has the meaning set forth in Section 8.2 below.

 

1.60         “Supplement”
means the prior approval Supplement filed by Seller with the FDA relating to a change in particle size of the active pharmaceutical
ingredients used in the Lithobid Products.

 

1.61         “Supply
Agreement” has the meaning set forth in the recitals above.

 

1.62         “Supply
Agreement Termination Letter” has the meaning set forth in Section 2.3(a)(iv) below.

 

1.63         “Tax
Return” means any return, declaration, report, claim for refund, information return or statement or other document relating
to Taxes, including any schedule or attachment thereto, and including any amendment thereof.

 

1.64         “Taxes”
(and with correlative meanings, “Tax” and “Taxable”) means all taxes of any kind imposed
by a federal, state, local or foreign governmental authority, including, but not limited to, those on, or measured by or referred
to as, income, gross receipts, financial operation, sales, use, ad valorem, value added, franchise, profits, license, withholding,
payroll (including all contributions or premiums pursuant to industry or governmental social security laws or pursuant to other
laws and regulations), employment, excise, severance, stamp, occupation, premium, property, transfer or windfall profits taxes,
customs, duties or similar fees, assessments or charges of any kind whatsoever, together with any interest, surcharges and penalties,
additions to tax or additional amounts imposed by such governmental authority with respect to such amounts.

 

1.65         “Third
Party” means any Person other than the Parties or any of their respective Affiliates.

 

1.66         “Threshold
Amount” has the meaning set forth in Section 8.3(a) below.

 

1.67         “Trade
Secrets” means information solely regarding the Lithobid Products, including technical and non-technical data, a formula,
pattern, compilation, program device, method, technique, process or other information similar to any of the foregoing, that (i) derives
economic value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by,
other Persons who can derive economic value from its disclosure or use and (ii) is the subject of efforts that are reasonable
under the circumstances to maintain its secrecy.

 

1.68         “Transfer
Letter” has the meaning set forth in Section 2.3(a)(iii).

 

Section
2     THE SALE

 

2.1           Sale
and Purchase; Assumption of Certain Liabilities.

 

(a)          At
the Closing, the Seller is selling, conveying, assigning, transferring, and, to the extent set forth in this Agreement, delivering
to the Buyer, and the Buyer is purchasing and assuming from the Seller, all of the Seller’s right, title and interest in
and to the following assets (collectively, the “Purchased Assets”):

 

(i)          the
Books and Records;

 

    	5

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

(ii)         the
Inventory, except for the Finished Lithobid Product Inventory;

 

(iii)        the
Product Approvals (to be effectuated as set forth in Section 2.4(b)); and

 

(iv)        all
the Intellectual Property Rights, including, without limitation, the Lithobid Marks and worldwide web addresses and domain names
listed on Schedule 2.1(a)(iv).

 

(b)          Notwithstanding
any other provision of this Agreement, the Purchased Assets do not include, and the Seller shall retain all rights, title and interest
in and to, all assets, properties and rights of the Seller and its Affiliates, including all finished Lithobid Product Inventory
bearing Seller’s NDC code (“Finished Lithobid Product Inventory”), other than those assets specifically
enumerated as Purchased Assets in Section 2.1(a) (collectively, the “Excluded Assets”). Without limiting
the generality of the foregoing, the Parties agree and acknowledge that the Purchased Assets shall not include any property, plant
or equipment, accounts receivable, cash, employees, or credit or refund of Taxes attributable to any period of time prior to the
Closing Date. Buyer acknowledges and agrees that Seller may retain a copy of all or part of the documentation that it delivers
to Buyer hereunder.

 

(c)          At
the Closing, as further consideration for the Purchased Assets, the Buyer shall only assume and agree to pay, perform and discharge
(i) all Liabilities and obligations arising out of the conduct of the Business and/or the operation and/or use of the Purchased
Assets by Buyer following the Closing, (ii) all product liability, product warranty and other Liabilities and obligations
arising out of or relating to the manufacture, distribution and/or sale of any Lithobid Products sold using Buyer’s NDC after
the Closing Date or the use thereof; (iii) all regulatory responsibilities relating to the Lithobid Products arising after
the Closing Date; (iv) notwithstanding any provision of this Agreement to the contrary, all Liabilities (including for product
liability, breach of warranty or any other action or claim) for which Buyer, ANIP Acquisition or any of their respective Affiliates
has Liability or in the future would have Liability pursuant to the Supply Agreement, including relating to voluntary and involuntary
recalls and market withdrawals of the Lithobid Product); and (v) any Liabilities relating to any clinical study or any data
associated therewith which arise from and after the Closing Date, if such clinical study was required or requested by any Regulatory
Authority after the Closing Date (collectively, the “Assumed Liabilities”).

 

(d)          All
Liabilities of the Seller other than the Assumed Liabilities (the “Retained Liabilities”) shall be retained
by and shall remain the sole responsibility of the Seller and its Affiliates, as applicable.

 

2.2           Consideration;
Allocation of Consideration.

 

(a)          As
consideration for the Purchased Assets, at the Closing, the Buyer is paying to Seller, the Closing Payment by wire transfer of
readily available US dollars to an account specified by Seller in writing.

 

(b)          In
the event that on or prior to June 30, 2015 the FDA informs Buyer that the FDA Review has been completed and the proposed Supplement
accepted without any additional requirement that Buyer conduct any further clinical trial in order to qualify or permit the requested
change to the Lithobid Products specified in the Supplement, then, no later than ten (10) Business Days following the Buyer’s
receipt of the approval thereof from the FDA, the Buyer will make an additional payment to Seller of One Million Dollars ($1,000,000),
by wire transfer of immediately available funds (the “Additional Payment”). However, in the event that in connection
with the FDA Review the FDA informs Buyer that any such further clinical trial is required or otherwise fails to approve the proposed
Supplement on or prior to June 30, 2015, then no Additional Payment shall be made by Buyer to Seller hereunder. Each Party shall
use (after Reasonable Commercial Efforts by Buyer to obtain such approval) Reasonable Commercial Efforts to obtain approval of
the Supplement. The aggregate of the Closing Payment plus any Additional Payment and the Assumed Liabilities is referred to herein
as the “Consideration”.

 

    	6

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

(c)          The
Consideration shall be allocated in accordance with Schedule 2.2 (the “Allocation Schedule”). Each
of the Parties agrees to (i) prepare and timely file all Tax Returns, in respect of all affected taxable periods (or portions
thereof), in a manner consistent with the Allocation Schedule, and (ii) act in accordance with the Allocation Schedule for
all Tax purposes, unless otherwise required by Law. Any unresolved disputes regarding the Allocation Schedule, including any amendments
thereto, shall be promptly submitted to a jointly-retained third party accounting firm for determination, which shall be final
and binding on the Parties. The cost and expenses of such third party accounting firm shall be borne equally by the Buyer and Seller.

 

(d)          Any
Taxes in the nature of a sales, transfer or use Tax payable on the sale or transfer of all or any portion of the Purchased Assets
or the consummation of any other transaction contemplated hereby (but specifically excluding any income tax liabilities) shall
be borne equally by the Seller and Buyer. The Buyer shall not be entitled to deduct and/or withhold from the Consideration otherwise
payable to Seller pursuant to this Agreement under any provision of federal, state, local or foreign Tax Law.

 

2.3           Closing.
The closing (the “Closing”) of the Sale is taking place on the Closing Date, concurrently with the execution
and delivery of this Agreement at the offices of Dentons US, LLP, located at 1221 Avenue of the Americas, New York, NY 10020.
The effective time of the Closing shall be 12:01 am, Eastern Daylight Time on the Closing Date. The parties hereby agree that
the Closing may take place by delivery of the documents to be delivered at the Closing by facsimile or other electronic transmission.
All deliveries by one party to another party at Closing shall be deemed to have occurred simultaneously and none shall be effective
until and unless all have occurred. At the Closing:

 

(a)          The
Seller shall deliver to the Buyer counterparts of the following documents, duly executed by the Seller (collectively referred to
herein as the “Ancillary Agreements”):

 

(i)          a
Bill of Sale and Assignment and Assumption Agreement effecting the transfer of the Purchased Assets and the assignment and assumption
of the Assumed Liabilities, in the form and substance of Exhibits A and B, respectively, hereto, executed by the
Seller;

 

(ii)         an
assignment of the Lithobid Marks, in the form and substance of Exhibit C, executed by the Seller;

 

(iii)        a
letter of transfer from Seller to the FDA in the form of Exhibit E (the “Transfer Letter”);

 

(iv)        a
letter from Seller confirming that the Supply Agreement is terminated except for Section 2.9, Article III, Article V, Article
VI, Article VII, Article VIII, Article XII and Article XIII (other than Section 13.9), in the form of Exhibit F (the
“Supply Agreement Termination Letter”); and

 

(v)         such
other documents, instruments and certificates as the Seller and Buyer reasonably agree are necessary to effect the transactions
herein described.

 

(b)          The
Buyer shall deliver to the Seller:

 

(i)          the
aggregate sum of Eleven Million Dollars ($11,000,000) (the “Closing Payment”) by wire transfer of immediately
available funds in accordance with Section 2.2(a);

 

(ii)         counterparts
of each of the Ancillary Agreements, duly executed by the Buyer as applicable;

 

    	7

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

(iii)        a
letter from Buyer to the FDA notifying it of Buyer’s acceptance of the transfer of the NDA referred to in the Transfer Letter
in the form of Exhibit G (“Buyer’s Acceptance Letter”); and

 

(iv)        the
Supply Agreement Termination Letter duly executed by ANIP Acquisition.

 

2.4           Transfer
of Purchased Assets; Cooperation.

 

(a)          On
or as promptly as practicable after the Closing Date, the Seller shall (i) transfer (or implement arrangements reasonably
satisfactory to Buyer for the transfer and delivery of physical possession of) all tangible assets included in the Purchased Assets
to the Buyer or its designated representatives, and (ii) upon request of the Buyer, notify all of its agents that hold files
or other tangible material included in the Purchased Assets that, effective as of the Closing, the Buyer owns such Purchased Assets,
with directions to transfer such Purchased Assets to Buyer in accordance with the Buyer’s instructions. Buyer shall pay for
any costs or expenses associated with taking possession of the Purchased Assets. Notwithstanding the foregoing, to the extent not
delivered at Closing, Seller shall deliver all of the non-electronic Books and Records related to the Product Approvals to Buyer
no later than August 1, 2014, and on or before July 15, 2014, except as otherwise provided in Section 5.12(c), Seller
shall provide to Buyer (1) all of the electronic Books and Records related to the Product Approvals, to the extent not previously
delivered and (2) all case files since April 27, 2014, including readable .pdf copies of PADER listings and completed FDA form
3500As and source documents.

 

(b)          Following
the Closing, Seller shall file with the FDA all of the documents and the information required of a former owner, including, but
not limited to, the Transfer Letter and Buyer shall file with the FDA the information required of a new owner or agent in respect
thereof in the form of the Buyer’s Acceptance Letter, in each case, at each Party’s own expense. Seller may retain
an archival copy of each Product Approval, including supplements and records that are required to be kept under 21 CFR §314.81.

 

(c)          Notwithstanding
anything to the contrary contained in this Agreement, if the sale, assignment, transfer, conveyance or delivery or attempted sale,
assignment, transfer, conveyance or delivery to the Buyer of any asset that would be a Purchased Asset is (i) prohibited by
any applicable Law or (ii) would require any authorization, approval, consent or waiver from a Third Party or Regulatory Authority
and such authorization, approval, consent or waiver shall not have been obtained prior to the Closing, then nothing contained herein
or in any Ancillary Agreement shall constitute or effect the sale, assignment, transfer, conveyance or delivery of any such asset.
In such event, following the Closing, the Parties shall use their Reasonable Commercial Efforts, and cooperate with each other
in good faith, to obtain promptly such authorization, approval, consent or waiver; provided, however, that the Buyer
shall not be required to pay any consideration or fee or otherwise incur any expense (all such consideration, fees and expenses
to be borne exclusively by the Seller) to obtain any such authorization, approval, consent or waiver. Pending such authorization,
approval, consent or waiver, the Parties shall cooperate with each other in good faith in any reasonable and lawful arrangements
that will provide to the Buyer the benefits of use of such asset, including any indemnities, that, in each case, it would have
obtained had the asset been conveyed to the Buyer at the Closing. If authorization, approval, consent or waiver for the sale, assignment,
transfer, conveyance or delivery of any such asset not sold, assigned, transferred, conveyed or delivered at the Closing is obtained,
the Seller shall assign, transfer, convey and deliver such asset to the Buyer at no additional cost to the Buyer.

 

(d)          Buyer
shall be responsible for, and shall bear all costs associated with, completing the recordation of any trademark assignment for
the Lithobid Marks with the appropriate Regulatory Authorities in each country in which the Lithobid Marks are registered; provided
that Seller shall, for a period of three (3) years after the Closing, upon the reasonable request of Buyer, cooperate with Buyer
to execute any additional documentation required to record and give effect to the assignment of the Lithobid Marks in any jurisdiction
in accordance with this Agreement.

 

    	8

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

  

Section
3REPRESENTATIONS AND WARRANTIES OF THE SELLER

 

Except as otherwise disclosed to Buyer in
the correspondingly numbered section of the disclosure schedules delivered to Buyer by the Seller on the date hereof, the Seller
hereby represents and warrants to the Buyer as follows:

 

3.1           Organization.
Seller is duly organized, validly existing and in good standing under the laws of Delaware.

 

3.2           Power
and Authorization. The execution and delivery by the Seller of this Agreement and each Ancillary Agreement, and the performance
of the Seller’s obligations hereunder and thereunder and the consummation of the Sale are within the power and authority
of the Seller and have been duly authorized by all necessary action on the part of the Seller. Each of this Agreement and each
Ancillary Agreement (a) has been duly executed and delivered by a duly authorized representative of the Seller and (b) is
a legal, valid and binding obligation of the Seller, enforceable against the Seller in accordance with its terms, except as enforceability
may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws now or hereafter in effect
relating to or affecting creditors’ rights generally.

 

3.3           Authorization
of Governmental Authorities. Except for actions and filings disclosed on Schedule 3.3 and for the Transfer Letter
and Buyer’s Acceptance Letter (and FDA’s acceptance thereof to the extent required), no action by or in respect of,
or filing with, any Regulatory Authority is required by the Seller for, or in connection with, the valid and lawful (i) authorization,
execution and delivery by the Seller of this Agreement and each Ancillary Agreement or (ii) the consummation of the Sale
by the Seller.

 

3.4           Noncontravention.

 

(a)          Except
as disclosed on Schedule 3.4(a), the execution, delivery and performance by the Seller of this Agreement and the Ancillary
Agreements do not (i) violate any Law or any decree or judgment of any court or other Regulatory Authority applicable to the
Seller, the Business or any of the Purchased Assets; (ii) violate or conflict with, result in a breach of, constitute a default
(or an event which, with or without notice or lapse of time or both, would constitute a default) under, permit cancellation of,
or result in the creation of any encumbrance (other than Permitted Encumbrances) upon any of the Purchased Assets under, any contract
to which the Seller is a party or by which it is bound (subject to Seller’s obtaining the consents set forth on Schedule 3.4(b));
or (iii) violate or conflict with any provision of the Certificate of Incorporation or By-laws of the Seller.

 

(b)          Except
as set forth on Schedule 3.4(b) and for the Transfer Letter and Buyer’s Acceptance Letter (and FDA’s acceptance
thereof to the extent required), no consents or approvals of, or filings or registrations by the Seller with any Regulatory Authority
or any other Third Party are necessary in connection with the execution, delivery and performance of this Agreement or the Ancillary
Agreements by the Seller.

 

3.5           Encumbrances.
Except as disclosed on Schedule 3.5 and except for Permitted Encumbrances and/or Encumbrances created by or at the
express direction of Buyer, there are no encumbrances on any of the Purchased Assets.

 

3.6           Purchased
Assets. At Closing, the Seller shall convey to the Buyer good and marketable title to and/or an enforceable right to use,
all of the Purchased Assets, subject to Encumbrances created by or at the express direction of Buyer.

 

    	9

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

3.7           Intellectual
Property.

 

(a)          The
current use by the Seller of the Intellectual Property Rights in the formulation, manufacture, packaging, promotion, distribution,
marketing, and sale of the Lithobid Products does not interfere with, infringe upon, misappropriate, or otherwise conflict with
any intellectual property rights of any Third Party. The Seller has not received any written charge, complaint, claim, demand,
or notice since June 1, 2011 alleging any interference, infringement, misappropriation, or violation (including any claim that
the Seller or any of its Affiliates must license or refrain from using any of the Intellectual Property Rights). To the Knowledge
of the Seller, no Third Party (i) currently interferes or has since June 1, 2011 interfered with, (ii) currently infringes
or has since June 1, 2011 infringed upon, or (iii) has since June 1, 2011 misappropriated any of the Intellectual Property
Rights.

 

(b)          Schedule 3.7(b)
identifies all current and unexpired trademark and patent registrations that have been issued to the Seller or its predecessors
that solely relate to the Lithobid Products. Each item identified in Schedule 3.7(b) is valid, subsisting and in full
force and effect, and the Seller has taken all reasonable steps necessary to maintain such registrations, including the payment
when due of all registration and maintenance fees and annuities and the filing of all necessary renewals, statements and certifications,
and all necessary material documents and certificates in connection with such registered Intellectual Property Rights have been
filed with the relevant patent, copyright or other governmental or Regulatory Authorities for the purposes of maintaining such
registered Intellectual Property Rights.

 

(c)          Section 3.6
(solely with respect to Product Approvals that constitute Intellectual Property Rights) and this Section 3.7 represent
the sole and exclusive representations and warranties of the Seller regarding Intellectual Property Rights and no other representation
and/or warranty in this Agreement shall apply to any Intellectual Property Rights.

 

3.8           Legal
Compliance.

 

(a)          Except
as disclosed on Schedule 3.8(a), since June 1, 2009, the Seller has conducted its operations as they pertain to the
Business in compliance, in all material respects, with all applicable Laws.

 

(b)          Except
as set forth on Schedule 3.8(b), the Seller has not received any written notice of a material violation of any applicable
Law from any Regulatory Authority relating to the Purchased Assets or Business, including the promotion, distribution, marketing,
and sale of the Lithobid Products since June 1, 2011.

 

(c)          Except
as set forth on Schedule 3.8(c), with respect to the Business, including the promotion, distribution, marketing, and
sale of the Lithobid Products, the Seller has not received in writing since June 1, 2011, any warning letters or other correspondence
from the FDA or any other Regulatory Authority in which the FDA or such other Regulatory Authority asserted that the promotion,
distribution, marketing, or use and sale of any Lithobid Product was not in compliance with applicable Law. Except as disclosed
on Schedule 3.8(b), with respect to the promotion, distribution, marketing, and sale of the Lithobid Products, there
has not been, since June 1, 2011, any product recall, market withdrawal or replacement, or post-sale warning conducted by or on
behalf of the Seller concerning the Lithobid Products or, to the Knowledge of the Seller, any product recall, market withdrawal
or replacement conducted by or on behalf of any Third Party as a result of any alleged defect in the Lithobid Products.

 

(d)          Seller
has provided to Buyer readable .pdf copies of all PADERs or PADER listings from 2004 through April 27, 2014 and Medwatch forms
for all expedited cases from 2009 through April 27, 2014. Since April 27, 2011 , each PADER and annual report relating to the Lithobid
Products was timely filed by the Seller with the FDA.

 

3.9           Litigation.
Except as disclosed on Schedule 3.9, there is no lawsuit relating to the Purchased Assets of which Seller has Knowledge,
or to the Knowledge of the Seller, threatened which would reasonably be expected to have a Material Adverse Effect on the Business.
There is no lawsuit pending, or to the Knowledge of the Seller, threatened, which in any manner challenges or seeks the rescission
of, or seeks to prevent, enjoin, alter or materially delay the consummation of, or otherwise relates to, this Agreement or the
Sale. The Seller is not the plaintiff in and currently does not intend to initiate any lawsuit involving the Purchased Assets.

 

    	10

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

3.10         Ordinary
Course. As of June 30, 2014, the Finished Lithobid Product Inventory at the Company’s three largest wholesalers in the
aggregate is not more than 1600 units. Schedule 3.10 sets forth a summary, by week, of the shipments of Lithobid Products
sold by or on behalf of the Seller to customers from April 1, 2014 through June 29, 2014.

 

3.11         AMP.
Schedule 3.11 sets forth the baseline Average Manufacturers Price (“AMP”) for the Lithobid Products
as of March 31, 2014. As of the Closing Date, Seller has delivered to Buyer any and all Books and Records relating to the calculation
of baseline AMP received by Seller from Solvay when Seller acquired the rights to Lithobid from Solvay (which for purposes of
clarity excludes any proprietary methodology documents created by Seller or any of Seller’s Affiliates with respect to the
calculation of baseline AMP).

 

3.12         No
Brokers. The Seller has no liability of any kind to, and is not subject to any claim of, any broker, finder or agent in connection
with the Sale other than those which will be borne by the Seller.

 

3.13         Solvency.
Immediately after giving effect to the Closing and the transactions contemplated by this Agreement, the Seller and each of its
subsidiaries will be able to pay their respective debts as they become due and shall own property which has a fair saleable value
greater than the amounts required to pay their respective debts (including a reasonable estimate of the amount of all contingent
liabilities). Immediately after giving effect to the transactions contemplated by this Agreement, the Seller and each of its subsidiaries
shall have adequate capital to carry on their respective businesses. No transfer of property is being made and no obligation is
being incurred in connection with the transactions contemplated by this Agreement with the intent to hinder, delay or defraud
either present or future creditors of the Seller or its subsidiaries.

 

3.14         No
Other Representations or Warranties; Schedules.

 

(a)          EXCEPT
FOR THE REPRESENTATIONS AND WARRANTIES EXPRESSLY SET FORTH IN SECTION 3, THE SELLER DISCLAIMS ALL LIABILITY AND RESPONSIBILITY
FOR ANY REPRESENTATION, WARRANTY, STATEMENT MADE OR INFORMATION COMMUNICATED (WHETHER ORALLY OR IN WRITING) TO BUYER, ITS AFFILIATES
AND REPRESENTATIVES (INCLUDING ANY OPINION, INFORMATION OR ADVICE WHICH MAY HAVE BEEN PROVIDED TO BUYER, ITS AFFILIATES OR REPRESENTATIVES
BY ANY DIRECTOR, OFFICER, EMPLOYEE, ACCOUNTING FIRM, LEGAL COUNSEL, OR OTHER AGENT, CONSULTANT, OR REPRESENTATIVE OF THE SELLER).
ANY AND ALL STATEMENTS MADE OR INFORMATION COMMUNICATED BY THE SELLER OR ANY OF ITS REPRESENTATIVES OUTSIDE OF THIS AGREEMENT (INCLUDING
BY WAY OF THE DOCUMENTS PROVIDED IN RESPONSE TO BUYER’S WRITTEN DILIGENCE REQUESTS AND ANY MANAGEMENT PRESENTATIONS PROVIDED),
WHETHER VERBALLY OR IN WRITING, ARE DEEMED TO HAVE BEEN SUPERSEDED BY THIS AGREEMENT, IT BEING INTENDED THAT NO SUCH PRIOR OR CONTEMPORANEOUS
STATEMENTS OR COMMUNICATIONS OUTSIDE OF THIS AGREEMENT, OR ANY WARRANTY OF MERCHANTABILITY OR WARRANTY OF FITNESS FOR A PARTICULAR
PURPOSE, SHALL SURVIVE THE EXECUTION AND DELIVERY OF THIS AGREEMENT.

 

Section
4     REPRESENTATIONS AND WARRANTIES OF THE BUYER

 

The Buyer hereby represents and warrants
to the Seller as of the date of this Agreement, as follows:

 

4.1           Organization.
The Buyer is duly organized, validly existing and in good standing under the laws of Delaware.

 

    	11

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

4.2           Power
and Authorization. The execution, delivery and performance by the Buyer of this Agreement and each Ancillary Agreement and
the consummation of the Sale are within the power and authority of the Buyer and have been duly authorized by all necessary action
on the part of the Buyer. Each of this Agreement and each Ancillary Agreement (a) has been duly executed and delivered by
a duly authorized representative of the Buyer and (b) is a legal, valid and binding obligation of the Buyer, enforceable
against the Buyer in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium or other similar laws now or hereafter in effect relating to or affecting creditors’ rights generally.

 

4.3           Authorization
of Governmental Authorities. No action by or in respect of, or filing with, any governmental authority is required by the
Buyer for, or in connection with, the valid and lawful (a) authorization, execution, delivery and performance by the Buyer
of this Agreement and each Ancillary Agreement or (b) the consummation of the Sale by the Buyer.

 

4.4           No
Brokers. The Buyer has no liability of any kind to, and is not subject to any claim of, any broker, finder or agent with respect
to the Sale for which the Buyer will be liable.

 

4.5           Noncontravention.

 

(a)          The
execution, delivery and performance by the Buyer of this Agreement and the Ancillary Agreements to which the Buyer is a party do
not and will not (i) violate any Law or any decree or judgment of any court or other Regulatory Authority applicable to the
Buyer; (ii) violate or conflict with, result in a breach of, constitute a default (or an event which, with or without notice
or lapse of time or both, would constitute a default) under, or permit cancellation of, any contract, agreement or obligation to
which the Buyer is a party or by which it is bound; or (iii) violate or conflict with any provision of the Certificate of
Incorporation or Bylaws of the Buyer.

 

(b)          Except
for any that have heretofore been obtained or made, no material consents or approvals of, or filings or registrations by the Buyer
with, any Regulatory Authority or any other Third Party are necessary in connection with the execution, delivery and performance
of this Agreement or the Ancillary Agreements by the Buyer.

 

4.6           Financial
Capability. The Buyer has sufficient funds or credit resources to pay the Consideration and to perform and consummate the
transactions contemplated by this Agreement, on the terms and subject to the conditions set forth herein.

 

4.7           Solvency.
Immediately after giving effect to the Closing and the transactions contemplated by this Agreement, the Buyer and each of its
subsidiaries will be able to pay their respective debts as they become due and shall own property which has a fair saleable value
greater than the amounts required to pay their respective debts (including a reasonable estimate of the amount of all contingent
liabilities). Immediately after giving effect to the transactions contemplated by this Agreement, the Buyer and each of its subsidiaries
shall have adequate capital to carry on their respective businesses. No transfer of property is being made and no obligation is
being incurred in connection with the transactions contemplated by this Agreement with the intent to hinder, delay or defraud
either present or future creditors of the Buyer or its subsidiaries.

 

Section
5    COVENANTS AND AGREEMENTS

 

5.1           Expenses.
Except to the extent otherwise expressly set forth in this Agreement, the Seller and the Buyer shall each bear their respective
expenses incurred in connection with the preparation, execution and performance of this Agreement, including, without limitation,
all fees and expenses of agents, representatives, counsel and accountants.

 

    	12

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

5.2           Payment
and Discharge of Liabilities. The Seller shall pay or otherwise satisfy in the ordinary course of business and as and when
due, whether before or after the Closing Date, all of the Retained Liabilities in accordance with the terms thereof and in a manner
consistent with their past practices in relation to the Business. The Buyer shall pay or otherwise satisfy in the ordinary course
of business and as and when due, after the Closing Date, all of the Assumed Liabilities.

 

5.3           Further
Assurances. Each Party shall exercise its Reasonable Commercial Efforts to execute such documents, further instruments of
transfer and assignment and other papers and take such further actions as may be reasonably required to carry out the provisions
hereof and the transactions contemplated hereby and by the Ancillary Agreements in accordance with the terms hereof and thereof.

 

5.4           Public
Announcements. Exhibit D sets forth Seller’s form of press release regarding the terms of this Agreement and the transactions
set forth herein, and, except as set forth in Section 9, none of the Parties or their respective Affiliates or their respective
directors, officers, employees and agents shall issue any press release or otherwise make any public statement in deviation or
contravention of the contents of such press release without the approval of Buyer, in the case of any disclosure by Seller, or
Seller in the case of a disclosure by Buyer.

 

5.5           Customer
Notifications. As promptly as practicable after the Closing Date, the Buyer and Seller shall send the joint letter attached
hereto as Exhibit H to all wholesale distributors, pharmacies and other customers of the Seller listed on Schedule 5.5.

 

5.6           NDC
Numbers. Buyer has established new National Drug Code (“NDC”) numbers for the Lithobid Products. The Buyer
shall apply such new NDC numbers to all Lithobid Products manufactured or sold on or after the Closing Date.

 

5.7           Access
After Closing.

 

(a)          Following
the Closing, for so long as such information is retained by the Buyer, the Buyer shall permit the Seller and its authorized representatives
to have reasonable access to, and to make photocopies of, the Books and Records transferred to the Buyer that relate to the Purchased
Assets with respect to the period prior to Closing, to the extent that such access may be required in connection with (i) the
preparation of any accounting records or Tax returns or any audit involving the Lithobid Products or the Purchased Assets, (ii) any
suit, claim, action, proceeding or investigation relating to the Purchased Assets, (iii) any regulatory filing or matter,
or (iv) in connection with any other valid legal or business purpose of the Seller or its Affiliates. Such access shall be
afforded during normal business hours and upon reasonable prior written notice from the Seller. The Buyer shall retain all Books
and Records of the nature described above for a period of six (6) years following the Closing Date unless the Buyer gives the Seller
notice of its intention to destroy any such records and affords the Seller a reasonable opportunity to take possession or make
copies of any such records proposed to be destroyed.

 

(b)          Subject
to Section 2.4(c), following the Closing, for so long as such information is retained by the Seller, the Seller shall permit
the Buyer and its authorized representatives to have reasonable access to, and to make photocopies of, the Books and Records retained
by the Seller that relate to the Purchased Assets with respect to the period prior to Closing, to the extent that such access may
be required in connection with (i) the preparation of any accounting records or Tax returns or any audit involving the Lithobid
Products or the Purchased Assets, (ii) any suit, claim, action, proceeding or investigation relating to the Purchased Assets,
(iii) any regulatory filing or matter or (iv) in connection with any other valid legal or business purpose of the Buyer
or its Affiliates. Such access shall be afforded during normal business hours and upon reasonable prior written notice from the
Buyer. The Seller shall retain all Books and Records of the nature described above for a period of six (6) years following the
Closing Date unless the Seller gives the Buyer notice of its intention to destroy any such records and affords the Buyer a reasonable
opportunity to take possession or make copies of any such records proposed to be destroyed.

 

    	13

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

5.8           Inventory.
Immediately following Closing, Seller and Buyer shall jointly notify Cardinal SPS in writing of the consummation of the Sale and
Seller shall instruct Cardinal SPS to destroy the Finished Lithobid Product Inventory held by Cardinal SPS, and Buyer shall destroy
any Finished Lithobid Product Inventory in its possession. Buyer shall pay or promptly reimburse Seller for any costs or expenses
associated with Cardinal SPS’s and/or Buyer’s destruction of the Finished Lithobid Product Inventory. All accounts
receivable and other amounts owed to Buyer or ANIP Acquisition or their respective Affiliates with respect to Inventory shall
be deemed paid and satisfied in full by Seller. Buyer and Seller each agrees that in no event following the Closing Date will
Buyer or Seller sell any Lithobid Products which are labeled with the Seller’s name. Not in any way limiting any provision
of this Agreement, Seller shall have no obligation to reimburse Buyer or ANIP Acquisition or their respective Affiliates for any
Methylene Chloride purchased by Buyer or ANIP Acquisition or their respective Affiliates pursuant to the terms of the Supply Agreement
or otherwise. Immediately following the Closing, Seller shall terminate its sample program with J. Knipper and Company and shall
promptly cause any Finished Lithobid Product Inventory in the possession of J. Knipper and Company to be destroyed, at the sole
cost and expense of Seller.

 

5.9           Regulatory
Matters.

 

(a)          Responsibility
for the Lithobid Products. From and after the Closing Date, except as otherwise required by Law, the Buyer shall be solely
responsible for all regulatory responsibilities under applicable Law, with respect to reporting and otherwise, in connection with
the Lithobid Products, including (i) all regulatory responsibility with respect to the formulation, manufacture, packaging,
promotion, distribution, marketing, use and sale of Lithobid Products; (ii) adverse drug experience reporting relating to
the Lithobid Products, and (iii) NDAs with respect to the Lithobid Products (it being understood and agreed that nothing in
this clause (a) shall in anyway be deemed to limit any right to indemnification Buyer and/or Seller may have under
Section 8).

 

(b)          Communications
with Regulatory Agencies. From and after the Closing Date, the Buyer shall have responsibility for all communication with the
FDA with respect to the matters relating to the formulation, manufacture, packaging, promotion, distribution, marketing, use and
sale of the Lithobid Products including without limitation, with respect to the Supplement and any clinical trials required following
the FDA Review. To the extent any such communication relates to the Supplement, Buyer shall consult with Seller regarding the content
of such communication and shall provide Seller with a copy of any material correspondence received from the FDA.

 

(c)          Fee
Obligations. From and after the Closing Date, Buyer shall assume all responsibility for any and all fee obligations for holders
or owners of approved INDs, NDAs and Regulatory Approvals relating to the Lithobid Products after the Closing Date, including those
defined under the Prescription Drug User Fee Act of 1992, as the same may be amended from time to time (it being understood and
agreed that nothing in this clause (c) shall in anyway be deemed to limit any right to indemnification Buyer and/or
Seller may have under Section 8).

 

5.10         Reporting
of and Response to Adverse Drug Experience Reports, Medical Inquiries and Product Complaints. From and after the Closing Date,
Buyer shall be responsible for responding to all adverse drug experience reports, complaints and medical inquiries with respect
to the Lithobid Products in accordance with applicable Law and the Buyer’s customary internal procedures for responding
to such reports, complaints and inquiries. These adverse drug experience reports and Lithobid Product complaints and medical inquiries
may arise from any sources such as (but not limited to) direct telephone calls, the filing of lawsuits, or written correspondence
to either Party. Following the Closing, the Seller shall refer all reports of adverse drug experience and Lithobid Product complaints
and medical inquiries that it receives to the Buyer within five (5) days after receipt thereof. As used herein, “adverse
drug experience” shall have the meaning set forth in 21 CFR 314.80.

 

    	14

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

5.11         Rebates;
Returns.

 

(a)          Each
Party shall be responsible, at its own cost and expense, for the processing, payment, administration and support of any rebates,
credits or allowances or other expenses for which it has contractual or other liability to any third party, regardless of when
incurred, which relate to or arise out of sales of the Lithobid Product under its own NDC number.

 

(b)          As
of the Closing, each Party shall be operationally responsible for processing, acceptance and exchange/refund with respect to the
return of all Lithobid Products bearing its NDC in accordance with its standard return terms and conditions. Financial responsibility
for returns shall be as follows: (i) Buyer shall be financially responsible for returns related to Lithobid Product sold bearing
its NDC number and (ii) Seller shall be financially responsible for returns related to Lithobid Products sold on or prior
to the Closing Date under its NDC number. If any quantities of Lithobid Products are returned after the Closing Date to a Party
that are properly allocated to the other Party as set forth above, the receiving Party shall inform the other Party as soon as
practicable and, (1) if the Seller has received the return, Seller shall deliver to Buyer (at Buyer’s expense if such return
is allocated to Buyer) or destroy, at Buyer’s election, such returned Lithobid Product, or (2) if the Buyer has received
the return and if such return is allocated to the Seller, Buyer shall destroy or return, at Seller’s election and expense,
such returned Lithobid Product. Seller shall direct any requests to exchange returned Lithobid Product to Buyer for handling.

 

5.12         Post-Closing
Cooperation. Following the Closing, the Parties agree to use Reasonable Commercial Efforts to transition the Business to the
Buyer. In this regard:

 

(a)          Seller
shall send a copy of the Transfer Letter to the FDA immediately following the Closing, and Buyer will send a copy of Buyer’s
Acceptance Letter to the FDA immediately following the Closing;

 

(b)          Seller
and Buyer shall cooperate to effect a transfer of the pharmacovigilance relating to the Lithobid Products on the Closing Date and
in this regard, Seller agrees to forward all customer inquiries, ADEs and customer questions received by it in respect of the Lithobid
Products to the call center of Buyer previously identified to Seller;

 

(c)          Seller
and Buyer shall cooperate to effect the transfer, at Buyer’s expense, of a copy of the Seller’s safety database with
respect to the Lithobid Products to Buyer (i.e., JDS files) no later than September 30, 2014; provided that such materials shall
be provided in exclusively electronic form except for documents related to the pre-2004 period that are solely available in paper
form;

 

(d)          Seller
shall promptly remove the Lithobid Products from the DailyMed website following the expiration of the last to expire lot of Lithobid
Products sold by Seller under Seller’s NDC code; and

 

(e)          Seller
shall provide Buyer with reasonable assistance with preparing any FDA sufficiency response, including with respect to any additional
information which is in the possession of Seller and requested by the FDA in connection with the Supplement. Buyer shall draft
any responses to deficiencies the FDA identifies with respect to the Supplement, and Seller shall use Reasonable Commercial Efforts
to provide Buyer with information it needs to prepare and file with the FDA the regulatory filings required to be filed by Buyer
for the manufacture, marketing and distribution of the Lithobid Products, including, without limitation, the applicable PADER and
NDA annual report for 2015 (with applicable domestic distribution data). Each Party shall pay their own expenses incurred in connection
with obtaining acceptance by the FDA of the Supplement; however, any third party costs, fees and/or other expenses associated with
obtaining acceptance by the FDA of the Supplement shall be paid by Buyer.

 

    	15

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

5.13         Buyer’s
Due Diligence Investigation.

 

(a)          Buyer
acknowledges and agrees that, for the purposes of this Agreement, none of the Seller, its Affiliates or representatives has made
any representations or warranties regarding the Seller, the Business, the Purchased Assets or otherwise in connection with the
transactions set forth herein or in the Ancillary Agreements, on which it relied other than the representations and warranties
expressly made by the Seller in Section 3. Without limiting the generality of the foregoing, Buyer acknowledges and agrees
that no projections, forecasts and predictions, other estimates, data, financial information, documents, reports, statements (oral
or written), summaries, abstracts, descriptions, presentations (including any management presentation or facility tour), memoranda,
or offering materials with respect to the Business or the Purchased Assets, is or shall be deemed to be a representation or warranty
by the Seller or any of its Affiliates to Buyer, under this Agreement, or otherwise, and that Buyer has not relied thereon in determining
to execute this Agreement and proceed with the transaction set forth herein. Buyer further acknowledges and agrees that to the
extent materials it has received from the Seller and its agents and representatives include projections, forecasts and predictions
relating to the Purchased Assets and the Business; that there are uncertainties inherent in attempting to make such projections,
forecasts and predictions; that Buyer is familiar with such uncertainties and is taking full responsibility for making its own
evaluation of the adequacy and accuracy of all projections, forecasts, predictions and information so furnished; that Buyer shall
not have any claims against the Seller, its officers, directors, Affiliates or representatives, with respect thereto; and that
Buyer has not relied thereon. Buyer acknowledges that no Person has been authorized by the Seller to make any representation or
warranty regarding the Seller, the Business, the Purchased Assets, or the transactions set forth in this Agreement and in the Ancillary
Agreements and, if made, such representation or warranty may not be relied upon as having been authorized by the Seller.

 

(b)          Buyer
acknowledges and agrees that it (i) has made its own inquiry and investigation into, and, based thereon and on the representations
and warranties set forth in Section 3 and has formed an independent judgment concerning, the Purchased Assets and the Business,
and (ii) has conducted such investigations of the Purchased Assets and the Business as Buyer deems necessary to satisfy itself
as to the operations and conditions thereof, and will rely solely on such investigations and inquiries, and the express representations
and warranties of the Seller set forth in Section 3. Buyer further acknowledges and agrees that it will not at any time
assert any claim against the Seller or any of its present and former directors, officers, managers, partners, shareholders, employees,
agents, Affiliates, consultants, investment bankers, attorneys, advisors or representatives, or attempt to hold any of such Persons
liable, for any inaccuracies, misstatements or omissions with respect to the information furnished by such Persons concerning the
Purchased Assets and/or the Business, other than any inaccuracies or misstatements in the representations and warranties expressly
set forth in Section 3 (subject to the limitations and expiration set forth in Section 8).

 

(c)          Further,
without limiting any representation, warranty or covenant of the Seller expressly set forth herein, Buyer acknowledges that it
has waived and hereby waives any further due diligence reviews, inspections or examinations with respect to the Seller, the Purchased
Assets and the Business, including with respect to financial, operational, regulatory and legal compliance matters.

 

Section
6        INTENTIONALLY OMITTED

 

Section
7       INTENTIONALLY OMITTED

 

Section
8          INDEMNIFICATION

 

    	16

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

8.1           Indemnification
by the Seller. Subject to the limitations set forth in this Section 8, the Seller will indemnify and hold harmless
the Buyer, its Affiliates and the Buyer’s and its Affiliates’ respective employees, officers, directors and representatives
(each, a “Buyer Indemnified Party”), from, against and in respect of any and all actions, liabilities, governmental
orders, encumbrances, losses, damages, bonds, dues, assessments, fines, penalties, Taxes, fees, costs, expenses (including reasonable
legal fees, costs and/or expenses incurred in defending a Third Party claim) or amounts paid in settlement (which, except in respect
of reasonable legal fees, costs and/or expenses incurred in defending a Third Party claim, shall be subject to the terms of Section 10.1(e))
(collectively, “Losses”), incurred or suffered by the Buyer Indemnified Parties or any of them as a result
of, arising out of, or directly or indirectly relating to: (a) any breach of, or inaccuracy in, any representation or warranty
made by the Seller in Section 3 of this Agreement; (b) any breach, nonperformance, or violation of any covenant or
agreement of the Seller (including, without limitation, under this Section 8) contained in this Agreement or any Ancillary
Agreement, or (c) any Retained Liability.

 

8.2           Indemnification
by the Buyer. The Buyer will indemnify and hold harmless the Seller, its Affiliates and the Seller’s and its Affiliates’
respective employees, officers, directors and representatives (each, a “Seller Indemnified Party”), from, against
and in respect of any and all Losses incurred or suffered by the Seller Indemnified Parties or any of them as a result of, arising
out of, or directly or indirectly relating to: (a) any breach of, or inaccuracy in, any representation or warranty made by
the Buyer in Section 4 of this Agreement; (b) any Assumed Liability asserted against any Seller Indemnified Party;
or (c) any breach, nonperformance, or violation of any covenant or agreement of the Buyer (including, without limitation,
under this Section 8) contained in this Agreement or any Ancillary Agreement.

 

8.3           Limits.

 

(a)          The
Buyer Indemnified Parties shall not be entitled to any indemnification in respect of Losses incurred by the Buyer Indemnified Parties
pursuant to Section 8.1(a) for breaches of non-Fundamental Representations unless and until the aggregate amount of
such Losses exceeds $[***] (the “Threshold Amount”), in which event if the aggregate amount of Losses
exceeds the Threshold Amount, the Buyer Indemnified Parties may only recover the amount of such Losses in excess of the Threshold
Amount. The maximum aggregate amount required to be paid by Seller to the Buyer Indemnified Parties pursuant to Section 8.1(a)
for breaches of non-Fundamental Representations shall not exceed $[***] (the “Cap”).
Not in any way limiting the provisions of this Section 8.3, the Seller will not have any obligation to indemnify the
Buyer Indemnified Parties pursuant to this Section 8 to the extent that the aggregate amount of all such Losses incurred
or suffered by such Indemnified Parties exceeds the Consideration paid by the Buyer. Notwithstanding the foregoing, the Threshold
Amount and Cap shall not apply to Losses arising out of or resulting from actual (and not constructive) fraud committed by the
Seller against the Buyer.

 

(b)          Except
as provided in this Section 8, nothing in this Agreement or any Ancillary Agreement shall impair, limit or otherwise affect
any indemnification obligation of either Party to the other Party arising under any other agreement, including the Supply Agreement,
between the Parties and any of their Affiliates. In this regard, it is understood and agreed that if any Losses for which Buyer
would otherwise be entitled to indemnification under Section 8.1 are finally determined to have been caused by any
occurrence for which Seller is otherwise entitled to indemnification under the Supply Agreement or any other act or omission by
Buyer, ANIP Acquisition or any of their respective Affiliates, Seller shall have no obligation to indemnify Buyer to the extent
thereof, and Buyer and its Affiliates shall indemnify Seller to the extent Seller is entitled to indemnification under the Supply
Agreement and/or this Agreement.

 

(c)          Buyer
shall use Reasonable Commercial Efforts to avoid or mitigate any Loss which it or any Buyer Indemnified Party may suffer in consequence
of any fact, matter or circumstance giving rise to a claim for indemnification under this Agreement or likely to give rise to a
claim for indemnification under this Agreement.

 

(d)          Where
the Seller has made a payment to a Buyer Indemnified Party in relation to any claim and Buyer Indemnified Party is entitled to
recover (whether by insurance, payment, discount, credit, relief or otherwise) from a Third Party a sum which indemnifies or compensates
Buyer Indemnified Parties (in whole or in part) in respect of the Liability or Loss which is the subject of a claim, Buyer or its
relevant Affiliates shall (i) promptly notify the Seller of the fact and provide such information as the Seller may reasonably
require, (ii) take all Reasonable Commercial Efforts as the Seller may require to enforce such right and (iii) pay to
the Seller, as soon as practicable after receipt, an amount equal to the amount recovered from the Third Party (net of taxation
and less any reasonable costs of recovery).

 

    	17

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

8.4           Time
for Claims. No claim may be made or suit instituted seeking indemnification pursuant to this Section 8 unless a written
notice describing the basis for such claim or suit in reasonable detail in light of the circumstances then known to the Indemnified
Party is provided to the Indemnifying Party:

 

(a)          at
any time prior to the expiration of the applicable statute of limitations, in the case of any claim or suit based upon a breach
or inaccuracy of the representations and warranties set forth in the first sentence and clause (a) of the second sentence
of Section 3.2 (Power and Authorization), Section 3.6 (Purchased Assets), Section 3.12 (No
Brokers), Section 4.2 (Power and Authorization) or Section 4.4 (No Brokers) (the “Fundamental
Representations”);

 

(b)          at
any time, and without limitation as to time, for any claim arising from the Retained Liabilities, Assumed Liabilities or any covenant
to be performed by either Party at or after the Closing (including with respect to the Additional Payment); or

 

(c)          at
any time prior to the twelve (12) month anniversary of the Closing Date, in the case of any claim or suit based upon a breach or
inaccuracy of the non-Fundamental Representations.

 

(d)          The
representations and warranties made by the Parties under this Agreement shall survive the Closing for a period contemporaneous
with the period during which the applicable Party may assert a claim in respect of a breach thereof, as set forth above in this
Section 8.4.

 

8.5           Procedure.
If any claim arises as to which a right of indemnification provided in this Section 8 may apply, the Indemnified Party
shall promptly provide a written notice to the Indemnifying Party for its claims for indemnification, and, to the extent applicable,
shall allow the Indemnifying Party and its insurers the opportunity to assume direction and control of the defense of such proceeding,
at its sole expense, subject to the limitations set forth in this Section 8, including the settlement thereof at the sole
option of the Indemnifying Party or its insurers; provided, however, that the Indemnifying Party may not enter into any compromise
or settlement without the prior written consent of the Indemnified Party, which will not be unreasonably delayed, conditioned
or withheld, unless such compromise or settlement is solely for monetary damages paid entirely by the Indemnifying Party and does
not include any admission of legal wrongdoing on the part of the Indemnified Party and contains an unconditional release of the
Indemnified Party, in which event no such consent shall be required. The Indemnified Party shall fully cooperate with the Indemnifying
Party and its insurer in the disposition of any such matter and the Indemnified Party will have the right and option to participate
in (but not control) the defense of any proceeding as to which this Section 8 applies, with separate counsel at its election
and cost. If the Indemnifying Party fails to assume or declines to assume the defense of any such proceeding within fifteen (15)
days after notice thereof, or fails to prosecute the defense of such claim in good faith and with reasonable diligence, or, in
the opinion of counsel to the Indemnified Party there is a conflict of interest between the Indemnifying Party and the Indemnified
Party, the Indemnified Party may assume the defense thereof for the account and at the risk of the Indemnifying Party (including
with respect to reasonable attorney’s fees in connection therewith, but subject to the limitations set forth in this Section
8). The Indemnifying Party shall pay promptly to the Indemnified Party any Losses to which the Indemnified Party is entitled
under this Section 8.

 

8.6           Exclusive
Remedy; Release. The Parties (and, by their acceptance of the benefits under this Agreement, each Buyer Indemnified Party
and Seller Indemnified Party) hereby agree that except as otherwise contemplated in Section 9.5, their sole and exclusive
remedy after the Closing with respect to any and all claims relating to this Agreement and the Sale shall be pursuant to the indemnification
provisions set forth in this Section 8. Notwithstanding the foregoing, this Section 8.6 shall not, and is in
no way intended to, restrict any Party’s (a) rights or obligations under any Ancillary Agreement or (b) right
to seek a temporary or permanent injunction and/or a decree for specific performance with respect to a breach or threatened breach
of a covenant or agreement contained in this Agreement. Each of the Parties agrees that, to the fullest extent permitted by applicable
Law, except to the extent of a breach of an express representation or warranty set forth in this Agreement in which case, the
other Party may seek recourse subject to and in accordance with this Section 8 only against the other Party, the respective
directors, officers, employees, affiliates, controlling persons, agents and representatives of the other Party shall not have
any personal liability or responsibility whatsoever to the claiming Party or any of its directors, officers, employees, Affiliates,
controlling persons, agents or representatives on any basis (including in contract or tort, under federal or state securities
laws or otherwise) based upon any information provided or made available, or statements made (or any omissions therefrom), to
the claiming Party or any of its directors, officers, employees, Affiliates, controlling persons, agents or representatives and
each Party hereby releases the other Party and its Affiliates’ respective directors, officers, employees, affiliates, controlling
persons, agents and representatives from any such liability or responsibility.

 

    	18

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

8.7           Limits
on Indemnification.

 

(a)          In
calculating amounts payable to an Indemnified Party, the amount of the Losses (i) shall not be duplicative of any other Loss
for which an indemnification claim has been made, and (ii) shall be computed net of any amounts actually recovered by such
Indemnified Party under any insurance policy with respect to such Loss, net of any reasonable out-of-pocket expenses actually incurred
in collecting such amounts. The Indemnified Party will use Reasonable Commercial Efforts to collect any amounts available under
such insurance coverage.

 

(b)          Neither
Party shall have any right to set off any Losses against any payments to be made by it or any of its Affiliates pursuant to this
Agreement or any Ancillary Agreement.

 

(c)          In
any case where an Indemnified Party recovers from Third Parties any amount in respect of a matter with respect to which an Indemnifying
Party has indemnified it pursuant to this Section 8, such Indemnified Party shall promptly pay over to the Indemnifying
Party the amount so recovered (after deducting therefrom the full amount of the expenses incurred by it in procuring such recovery),
but not in excess of the sum of (i) any amount previously so paid by the Indemnifying Party to or on behalf of the Indemnified
Party in respect of such matter and (ii) any amount expended by the Indemnifying Party in pursuing or defending any claim
arising out of such matter.

 

8.8           Treatment
of Indemnification Payment by Seller. Any indemnification payment made by Seller hereunder shall be treated as a reduction
of the Consideration for Tax purposes.

 

8.9           Consequential
Damages. NOTWITHSTANDING ANYTHING TO THE CONTRARY CONTAINED HEREIN, NO PARTY SHALL BE LIABLE TO ANY OTHER PARTY FOR SPECIAL,
CONSEQUENTIAL, INDIRECT OR INCIDENTAL (INCLUDING WITHOUT LIMITATION LOST PROFITS), PUNITIVE OR ANY MEASURE OF DAMAGES BASED ON
DIMINUTION OF VALUE OR ANY MULTIPLE OF EARNINGS, EBITDA, CASH FLOW OR SIMILAR CONCEPT UNDER THIS AGREEMENT EXCEPT TO THE EXTENT
SUCH DAMAGES SHALL BE PAYABLE TO A THIRD PARTY.

 

Section
9    CONFIDENTIALITY

 

9.1           General.
Pursuant to the terms of this Agreement, the Seller and the Buyer (in such capacity, the “Disclosing Party”)
have each disclosed and will be disclosing to the other Party, and to its Affiliates and to their respective officers, directors,
employees, agents and/or representatives (in such capacity, the “Receiving Party”) certain secret, confidential
or proprietary data, Trade Secrets, Know-How, intellectual property, Product Technology and related information, including, without
limitation, operating methods and procedures, marketing, manufacturing, distribution and sales methods and systems, sales figures,
pricing policies and price lists and other business information (“Confidential Information”). For purposes
of the preceding definition, Confidential Information included in the Purchased Assets shall be deemed Confidential Information
of the Buyer from and after the Closing. The Receiving Party shall make no use of any Confidential Information of the Disclosing
Party except in the exercise of its rights and the performance of its obligations set forth in this Agreement or the Ancillary
Agreements. The Receiving Party (i) shall keep and hold as confidential, and shall cause its officers, directors, employees,
agents and representatives to keep and hold as confidential, all Confidential Information of the Disclosing Party, and (ii) shall
not disclose, and shall cause its officers, directors, employees, agents and representatives not to disclose, any Confidential
Information of the Disclosing Party. Confidential Information disclosed by the Disclosing Party shall remain the sole and absolute
property of the Disclosing Party, subject to the rights granted in this Agreement or the Ancillary Agreements.

 

    	19

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

9.2           Exceptions.
The above restrictions on the use and disclosure of Confidential Information shall not apply to any information which (i) is
already known to the Receiving Party at the time of disclosure by the Disclosing Party (other than Confidential Information which
forms a part of the Purchased Assets), as demonstrated by competent proof (other than as a result of prior disclosure under any
agreement between the Parties with respect to confidentiality) or (ii) is or becomes generally available to the public other
than through any act or omission of the Receiving Party in breach of this Agreement or the Ancillary Agreements. In addition,
nothing in this Section 9 shall be interpreted to limit the ability of either Party to use or disclose its own Confidential
Information in any manner or to any other Person.

 

9.3           Permitted
Disclosures. It shall not be a breach of Section 9.1 if a Receiving Party discloses Confidential Information of
a Disclosing Party (including any terms of this Agreement) (i) pursuant to a binding requirement of applicable Law or a Regulatory
Authority, including obligations under securities Laws or rules or regulations of any securities exchange or market on which the
Disclosing Party’s or its Affiliates’ stock is traded, or (ii) in a judicial, administrative or other legal proceeding
to enforce or defend such Party’s rights under this Agreement. In such event, the Receiving Party shall (A) provide
the Disclosing Party with as much advance written notice as possible and as legally permissible of the required disclosure, (B) reasonably
cooperate with the Disclosing Party in any attempt to prevent or limit the disclosure at the sole cost of the Disclosing Party,
and (C) limit disclosure, if any, to the specific purpose at issue, or in the case of a disclosure under subsection (i)
of this Section 9.3, to the extent required by such Law or Regulatory Authority. Without limiting the generality of
the foregoing, if Buyer determines that it is required to file this Agreement as a material agreement under applicable securities
laws, it shall use Reasonable Commercial Efforts to seek to incorporate the reasonable confidential treatment requests of Seller
with respect to such disclosure, it being understood and agreed that neither the names of the Lithobid Products nor the Consideration
paid will be the subject of any such confidential treatment request.

 

9.4           Confidential
Terms. Each Party acknowledges and agrees that the terms and conditions of this Agreement shall be considered Confidential
Information of each Party and shall be treated accordingly.

 

9.5           Equitable
Remedies. Each Party specifically recognizes that any breach by it of this Section 9 may cause irreparable injury to
the other Parties and that actual damages may be difficult to ascertain, and in any event, may be inadequate. Accordingly (and
without limiting the availability of legal or equitable, including injunctive, remedies under any other provisions of this Agreement),
each Party agrees that in the event of any such breach, notwithstanding the provisions of Section 8.6, the other Parties
shall be entitled to seek, by way of private litigation in the first instance, injunctive relief and such other legal and equitable
remedies as may be available.

 

Section
10      DISPUTE RESOLUTION

 

10.1         Jurisdiction;
Venue; Service of Process.

 

(a)          Each
party, by its execution hereof, (a) hereby irrevocably attorns and submits to the exclusive jurisdiction of the state and
federal courts of New York located in New York City, New York, for the purpose of any action between or among the parties (or any
of them) arising in whole or in part under or in connection with this Agreement, (b) hereby waives and agrees not to assert,
by way of motion, as a defense or otherwise, in any such action, any claim that it is not subject personally to the jurisdiction
of the above-named courts, that its property is exempt or immune from attachment or execution, that any such action brought in
one of the above-named courts should be dismissed on grounds of forum non conveniens, should be transferred or removed to any court
other than one of the above-named courts, or should be stayed by reason of the pendency of some other proceeding in any other court
other than one of the above-named courts, or that this Agreement or the subject matter hereof may not be enforced in or by such
court and (c) hereby agrees not to commence any such action (including for a declaratory judgment or the like) other than
before one of the above-named courts.

 

    	20

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

(b)          Each
party agrees that for any action between the parties arising in whole or in part under or in connection with this Agreement, such
party will bring actions only in the State of New York, in a state or federal court located in New York City, New York. Each party
further waives any claim and will not assert that venue should properly lie in any other location within the selected jurisdiction.

 

(c)          Each
party hereby (a) consents to service of process in any action between the parties arising in whole or in part under or in
connection with this Agreement in any manner permitted by the Laws of the State of New York, (b) agrees that service of process
made in accordance with clause (a) or made by registered or certified mail, return receipt requested, at its address
specified pursuant to Section 11.1, will constitute good and valid service of process in any such action and (c) waives
and agrees not to assert (by way of motion, as a defense, or otherwise) in any such action any claim that service of process made
in accordance with clause (a) or (b) does not constitute good and valid service of process.

 

(d)          THE
PARTIES HEREBY WAIVE, AND COVENANT THAT THEY WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE), ANY RIGHT TO TRIAL
BY JURY IN ANY ACTION ARISING IN WHOLE OR IN PART UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED
HEREIN, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE. THE PARTIES AGREE THAT
ANY OF THEM MAY FILE A COPY OF THIS PARAGRAPH WITH ANY COURT AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY AND BARGAINED-FOR AGREEMENT
AMONG THE PARTIES IRREVOCABLY TO WAIVE THEIR RIGHTS TO TRIAL BY JURY IN ANY ACTION WHATSOEVER BETWEEN OR AMONG THEM RELATING TO
THIS AGREEMENT OR ANY OF THE TRANSACTIONS CONTEMPLATED HEREIN, WHICH ACTION WILL INSTEAD BE TRIED IN A COURT OF COMPETENT JURISDICTION
BY A JUDGE SITTING WITHOUT A JURY.

 

(e)          In
the event of litigation between the Parties arising from or regarding this Agreement, each Party shall bear its own costs and expenses
incurred in connection with the litigation.

 

Section
11      MISCELLANEOUS

 

11.1         Notices.
Any notice or other communication required or permitted hereunder shall be in writing and shall be deemed given when so delivered
in person, by reputable overnight courier, by facsimile transmission (with receipt confirmed by automatic transmission report)
or two (2) Business Days after being sent by registered or certified mail (postage prepaid, return receipt requested), as follows:

 

if to the Seller, to:

 

c/o Noven Pharmaceuticals

350 Fifth Avenue, 37th Floor

New York, NY 10118

Attn: General Counsel

Facsimile: 305-232-1836

 

    	21

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

with a copy to:

 

Greenberg Traurig, P.A.

333 S.E. 2nd Avenue

Miami, Florida 33131

Attn: David A. Barkus, Esq.

Facsimile: (305) 961-5724

 

if to the Buyer, to:

 

ANI Pharmaceuticals, Inc.

210 Main Street Baudette, Minnesota 56623

Attn: Chief Executive Officer

Facsimile: 218-634-3540

 

with a copy to:

 

Dentons US LLP

1221 Avenue of the Americas

New York, NY 10020

Attn: Paul A Gajer, Esq.

Facsimile: 212-768-6800

 

Either Party may by notice given in accordance with this Section 11.1
to the other Parties designate another address or Person for receipt of notices hereunder.

 

11.2         Amendment;
Waiver. This Agreement may not be amended except by an instrument signed by each of the Parties hereto. Any Party hereto may
(a) extend the time for the performance of any of the obligations or other acts of another Party hereto or (b) waive
compliance with any of the agreements of another Party or any conditions to its own obligations, in each case only to the extent
such obligations, agreements, or conditions are intended for its benefit; provided, however, that any such extension or waiver
shall be binding upon a Party only if such extension or waiver is set forth in a writing executed by such Party.

 

11.3         Entire
Agreement. This Agreement and the Ancillary Agreements contain the entire agreement between the Parties with respect to the
Sale and supersede all prior agreements, written or oral, between the Parties with respect thereto, including that certain Letter
of Intent between the Seller and the Buyer, dated May 1, 2014, which is hereby deemed terminated and of no further force and effect,
and, except for Section 2.9, Article III, Article V, Article VI, Article VII, Article VIII, Article XII and Article XIII
(other than Section 13.9) of the Supply Agreement, the Supply Agreement (including all purchase orders thereunder) shall
automatically terminate effective as of the Closing, and the Quality Assurance Agreement, dated July 1, 2008, shall automatically
terminate effective as of the Closing.

 

11.4         Governing
Law. This Agreement shall be governed by and construed exclusively in accordance with the internal laws of the State of New
York.

 

11.5         Binding
Effect; No Assignment; No Third-Party Beneficiaries.

 

(a)          This
Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns.
Neither the Seller nor the Buyer may assign any of its rights or delegate any of its liabilities or obligations hereunder without
the prior written consent of the other; provided, that either Party may assign its rights and obligations under this Agreement
without the other Party’s prior written consent upon written notice to the other Party in connection with the transfer or
sale of all or substantially all of the assets or business of such Party or any of its Affiliates or the merger or consolidation
with another Person of such Party or any of its Affiliates; provided that no assignment or delegation hereunder shall limit or
effect the assignor’s obligations hereunder; and, provided further, that the Buyer may provide its lenders
with a security interest in its rights under this Agreement in accordance with the terms of their security and collateral agreements
in connection with any credit facility provided by such lenders to the Buyer and that such lenders may foreclose upon such security
interest in accordance with the terms of such security and collateral agreements.

 

    	22

    	 

    

 

Confidential Materials Omitted and Filed
Separately with the Securities and Exchange 

Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the

Securities Act of 1933, as amended. Confidential Portions are marked: [***]

 

(b)          Nothing
in this Agreement, express or implied, is intended to or shall confer upon any Person other than the Parties and their respective
successors and permitted assigns any right, benefit or remedy of any nature whatsoever under or by reason of this Agreement.

 

11.6         Section
Headings; Construction; Interpretation. The headings of Sections in this Agreement are provided for convenience only and will
not affect its construction or interpretation. All references to “Section” or “Sections” refer to the
corresponding Section or Sections of this Agreement. All schedules and exhibits attached to this Agreement constitute an integral
part of this Agreement and are incorporated herein. Unless the context of this Agreement clearly requires otherwise, (a) the
singular shall include the plural and the plural shall include the singular wherever and as often as may be appropriate; (b) the
masculine shall include the feminine and the feminine shall include the masculine wherever or as often as may be appropriate;
(c) the words “include” and “including” shall mean “including without limitation”, and
(d) the words “hereof,” “herein,” “hereunder,” and similar terms in this Agreement shall
refer to this Agreement as a whole and not any particular Section or article in which such words appear.

 

11.7         Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, and all of which together
shall constitute one and the same instrument.

 

11.8         Severability.
If any provision of this Agreement is held invalid or unenforceable in any legal proceeding held pursuant to Section 10,
the other provisions of this Agreement shall remain in full force and effect. Any provision of this Agreement held invalid or
unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable. The
Parties further agree to replace such invalid or unenforceable provision of this Agreement with a valid and enforceable provision
that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable provision.

 

11.9         Rules
of Construction. The Parties hereto agree that they have been represented by counsel during the negotiation and execution
of this Agreement and, therefore, waive the application of any law, regulation, holding or ruling of construction providing that
ambiguities in an agreement or other document will be construed against the Party drafting such agreement or document.

 

11.10         Bulk
Sales Laws. The Parties hereto waive compliance with the requirements of the applicable Bulk Sales Laws in connection with
the consummation of the transactions contemplated hereby.

 

11.11         Independent
Contractor. Neither the Seller nor the Buyer, together in each case with their respective employees or representatives, are
under any circumstances to be considered as employees, agents, representatives, partners or joint venturers of the other by virtue
of this Agreement, and neither shall have the authority or power to bind the other or contract in the other’s name.

 

11.12         No
Implied Waivers. No failure on the part of the Seller or the Buyer to exercise and no delay in exercising any right, power,
remedy or privilege under this Agreement, or provided by statute or at law or in equity or otherwise, including the right or power
to terminate this Agreement, shall impair, prejudice or constitute a waiver of any such right, power, remedy or privilege or be
construed as a waiver of any breach of this Agreement or as an acquiescence therein, nor shall any single or partial exercise
of any such right, power, remedy or privilege preclude any other or further exercise thereof or the exercise of any other right,
power, remedy or privilege.

 

[Remainder of page intentionally left
blank]

 

    	23

    	 

    

  

IN WITNESS WHEREOF, the Parties have executed
this Agreement as of the date first stated above.

 

	 	NOVEN THERAPEUTICS, LLC
	 	 
	 	By:  	/s/ Jeffrey Eisenberg
	 	Name: Jeffrey Eisenberg
	 	Title:  Authorized Representative
	 	 
	 	ANI PHARMACEUTICALS, INC.
	 	 
	 	By: 	 /s/ Charlotte C. Arnold
	 	Name: Charlotte C. Arnold
	 	Title: Vice President & Chief Financial Officer

 

[Signature Page to Asset Purchase Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}]]